Introduction {#s1}
============

The Sin3a protein is a core component of a mammalian transcriptional corepressor complex that includes histone deacetylases (Hdacs) ([@bib15]; [@bib54]). Although Sin3a does not bind DNA on its own, it provides a scaffold for several transcription factors with specific DNA binding activities and thereby promotes the recruitment of Hdacs to and consequent repression of specific target genes. Mice lacking Sin3a die during embryogenesis around the time of implantation ([@bib27]), suggesting that the Sin3a-Hdac complex is essential for early embryonic development. Although this complex was initially thought only to repress gene expression, it can also stimulate transcription in a manner dependent on cellular context ([@bib17]).

Gene expression is also regulated by DNA methylation. In mammals, DNA methylation occurs predominantly at CpG sequences, with \~70% of gene promoters in mammalian genomes containing CpG islands. In general, CpG islands of transcriptionally active promoters are not methylated, whereas methylation of CpG in a promoter is associated with transcriptional silencing. During mouse development, the methylation pattern of genomic DNA is established at the peri-implantation stage by the de novo methyltransferases Dnmt3a and Dnmt3b. Once established, this methylation pattern is faithfully maintained by Dnmt1 during DNA replication. The precise formation and maintenance of the DNA methylation pattern are essential for mouse embryogenesis, given that embryos lacking Dnmt enzymes develop pronounced morphological defects and die in utero ([@bib24]; [@bib32]).

Methylated DNA can undergo demethylation, a process mediated by the Tet family of 5-methylcytosine dioxygenases that catalyze the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) ([@bib46]). Demethylation of DNA by Tet proteins serves to activate gene promoters, but these proteins are also able to regulate gene expression via histone modification ([@bib49]; [@bib50]). Strict regulation of Tet proteins is also required for proper development, given that mouse embryos lacking Tet1 and Tet2 as well as chimeric embryos that include cells deficient in Tet1, Tet2, and Tet3 become malformed ([@bib8]; [@bib9]). The mechanisms responsible for such Tet regulation have remained unknown, however.

We have previously identified *Fam60a* (*Sinhcaf*) as a gene of unknown function (gene 226 reported in \[[@bib34]\]) that is highly expressed in mouse embryonic stem (ES) cells and whose expression in these cells is down-regulated on their differentiation. We have now examined the role of Fam60a in mouse development. Our data show that Fam60a is an embryonic component of the Sin3a-Hdac corepressor complex and regulates gene expression at least in part by regulating DNA methylation at a subset of gene promoters.

Results {#s2}
=======

Fam60a interacts with components of the Sin3a-Hdac complex {#s2-1}
----------------------------------------------------------

To examine the biochemical function of Fam60a, we generated mice harboring a *Fam60a::Venus* BAC (bacterial artificial chromosome) transgene ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}; as described below, the Fam60a-Venus fusion protein encoded by this transgene is functional). Immunostaining revealed that the Fam60a-Venus protein was present in nuclei of embryonic day (E) 9.5 embryos harboring the transgene, and that Fam60a was localized to the nucleus of undifferentiated P19 (mouse embryonic carcinoma) cells ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

To identify proteins that might interact with Fam60a, we prepared nuclear extracts from E10.5 embryos harboring the *Fam60a::Venus* transgene under three different conditions, subjected the extracts to immunoprecipitation with antibodies to green fluorescent protein (GFP), and analyzed the precipitated proteins by mass spectrometry. The major proteins identified were Arid4a, Arid4b, Sin3a, Sap130, Hdac1, Hdac2, Suds3, and Brms1l ([Figure 1A](#fig1){ref-type="fig"}), all of which are components of the Sin3a-Hdac corepressor complex ([@bib7]; [@bib10]; [@bib12]; [@bib31]; [@bib38]; [@bib40]). Arid4a and Arid4b were not detected if nuclear extracts were prepared with radioimmunoprecipitation assay (RIPA) buffer ([Figure 1A](#fig1){ref-type="fig"}), the most stringent of the three conditions used, suggesting that these proteins interact weakly with the other components of the Sin3a-Hdac complex ([@bib22]).

![Identification of Fam60a-interacting proteins in mouse embryos.\
(**A**) Nuclear lysates prepared under three different conditions from E10.5 embryos harboring the *Fam60a::Venus* transgene were subjected to immunoprecipitation with bead-coupled antibodies to GFP that either had (control) or had not been previously exposed to recombinant GFP. Proteins that bound to the beads were then fractionated by SDS-polyacrylamide gel electrophoresis and revealed by silver staining. Proteins that bound nonspecifically to the beads are indicated by asterisks, and the identity of those that bound specifically was determined by mass spectrometry. The bead-bound proteins were also subjected to immunoblot (IB) analysis with antibodies to GFP for detection of Fam60a-Venus. (**B**) Nuclear extracts of E10.5 WT embryos, undifferentiated P19 cells, or E10.5 embryos harboring the *Fam60a::Venus* transgene were subjected to immunoprecipitation (IP) with bead-coupled anti-Fam60a, anti-GFP, or control rabbit immunoglobulin G (IgG), as indicated, and the resulting precipitates were subjected to immunoblot analysis with antibodies to Sin3a, to Hdac1, and to Hdac2 (upper panel). The nuclear extracts (Input) as well as the material that bound nonspecifically to beads before exposure to the antibodies used for immunoprecipitation (Preclear) were also subjected to immunoblot analysis. Alternatively, nuclear extracts of E10.5 WT embryos were subjected to immunoprecipitation with antibodies to Sin3a, to Hdac1, to Hdac2, or to the FLAG epitope (control), and the resulting precipitates were subjected to immunoblot analysis with antibodies to Fam60a (lower panel). See also [Figure 3---figure supplement 1 to 3](#fig3s1){ref-type="fig"}.](elife-36435-fig1){#fig1}

Further co-immunoprecipitation analysis confirmed that Fam60a interacts with components of the Sin3a-Hdac complex. Immunoprecipitates prepared from nuclear extracts of E10.5 wild-type (WT) embryos with antibodies to Fam60a were thus found to contain Sin3a, Hdac1, and Hdac2 ([Figure 1B](#fig1){ref-type="fig"}). In addition, these three proteins were detected in immunoprecipitates prepared from nuclear extracts of *Fam60a::Venus* transgenic embryos with antibodies to GFP ([Figure 1B](#fig1){ref-type="fig"}). Immunoprecipitates prepared from undifferentiated P19 cells with antibodies to Fam60a also contained Sin3a and Hdac1 but not Hdac2 ([Figure 1B](#fig1){ref-type="fig"}). Reciprocal co-immunoprecipitation analysis with nuclear extracts of E10.5 WT embryos revealed that Fam60a was present in immunoprecipitates prepared with antibodies to Sin3a or to Hdac1 but not in those prepared with antibodies to Hdac2 ([Figure 1B](#fig1){ref-type="fig"}), suggesting that the association between Hdac2 and Fam60a is relatively weak. Together, these data indicated that Fam60a is a component of the Sin3a-Hdac corepressor complex in developing mouse embryos and in undifferentiated P19 cells. This is consistent with recent findings that Fam60a is a core subunit of a variant Sin3a complex in ES cells ([@bib43]). Formation of the Sin3a-Hdac complex was not affected by the absence of Fam60a, however, given that Hdac1, Hdac2, and RbAp46/48 were co-immunoprecipitated with Sin3a from *Fam60a*^--/--^ ES cells ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}).

*Fam60a* expression in mouse embryos and adult intestine {#s2-2}
--------------------------------------------------------

To shed light on the physiological function of Fam60a, we first examined the pattern of *Fam60a* expression during mouse embryogenesis. Expression of *Fam60a* was ubiquitous at E9.5, but it gradually became restricted to a subset of cells as development proceeded ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). At E12.5, *Fam60a* expression was thus apparent in the neural tube, neural crest cells, lung, pancreas, and intestine, but not in liver. Epithelial cells of the intestinal tract showed a high level of *Fam60a* expression at E15.5 ([Figure 2A](#fig2){ref-type="fig"}), and intervilli of the intestinal tract continued to express *Fam60a* at E17.5 ([Figure 2B and C](#fig2){ref-type="fig"}). In adult mice, Fam60a expression was maintained in crypts of the duodenum ([Figure 2D--F](#fig2){ref-type="fig"}). Given that intestinal stem and progenitor cells reside in crypts, we examined the fate of Fam60a^+^ cells in crypts by administering tamoxifen to adult mice harboring a *Fam60a-CreERT2* transgene and *lacZ* reporter gene. Examination of the mice at 1, 3, and 5 days after tamoxifen injection revealed that LacZ^+^ cells were present at the base of intestinal villi at 1 day and that they subsequently migrated toward the tip of the villi during the next 4 days ([Figure 2G--I](#fig2){ref-type="fig"}). These data thus suggested that *Fam60a* is expressed in a subset of cells including somatic stem cells in the intestine.

![Expression of *Fam60a* in embryonic and adult mouse intestine.\
(**A--C**) In situ hybridization analysis of *Fam60a* expression in sections of mouse embryonic intestine at E15.5 (**A**) and E17.5 (**B** and **C**). *Fam60a* is expressed in epithelial cells of the gastrointestinal tract at E15.5 and in intervilli of the intestine at E17.5. A higher magnification view of the image in (**B**) is shown in (**C**). Scale bars, 100 µm. (**D--F**) Immunohistochemical analysis of Fam60a expression in the adult duodenum. Staining for a wild-type mouse was performed without primary antibodies as a control (**D**) or with antibodies to Fam60a (**E**), and that for a mouse harboring a *Fam60a::Venus* transgene was performed with antibodies to GFP (**F**). Scale bars, 100 µm. (**G--I**) Lineage trace analysis of LacZ^+^ cells (stained with the LacZ substrate X-gal) in intestinal villi of the duodenum at 1, 3, or 5 days, respectively, after injection of tamoxifen (6 mg) in adult mice harboring a *Fam60a-CreERT2* transgene and *lacZ* reporter gene. Scale bar, 500 µm. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.](elife-36435-fig2){#fig2}

Developmental defects in *Fam60a* mutant mice {#s2-3}
---------------------------------------------

We next generated mice lacking *Fam60a*. Two types of mutant allele were generated: *Fam60a*^--^ and *Fam60a*^βgeo^ ([Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}). *Fam60a*^--/--^ and *Fam60a*^βgeo/βgeo^ mice showed indistinguishable phenotypes, suggesting that both alleles are functionally null, with subsequent analyses being performed with *Fam60a*^--/--^ mice unless indicated otherwise. Both types of heterozygote also appeared indistinguishable from WT mice. We confirmed that *Fam60a* mRNA and Fam60a protein were absent in *Fam60a*^--/--^ embryos ([Figure 3---figure supplement 1C and D](#fig3s1){ref-type="fig"}, [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). *Fam60a*^--/--^ mice were born at a frequency much lower than that expected. They were detected at the expected frequency at E9.5 and E10.5, but their number started to decline thereafter and was greatly decreased at E18.5 ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Examination of *Fam60a*^--/--^ embryos at E13.5 revealed that many visceral organs including the heart, lungs, liver, and gut were markedly smaller than those of WT embryos ([Figure 3A--C](#fig3){ref-type="fig"}). In particular, hypoplasia of the right ventricle of the heart was apparent, and a ventricular septum defect was also frequently observed, in *Fam60a*^--/--^ embryos ([Figure 3D](#fig3){ref-type="fig"}). *Fam60a* was expressed in the developing heart, predominantly in the right ventricle and outflow tract, of WT embryos at E13.5 ([Figure 3G](#fig3){ref-type="fig"}). Many of the *Fam60a*^--/--^ embryos that survived to E18.5 manifested transposition of the great arteries, double-outlet right ventricle, and ventricular septum defects as well as spleen hypoplasia, incomplete lobulation of the lungs, and abnormal rotation of the gut ([Figure 3---figure supplements 2](#fig3s2){ref-type="fig"} and [3](#fig3s3){ref-type="fig"}). Although these abnormalities appeared reminiscent of laterality defects, left-right asymmetric expression of *Pitx2* was maintained at E8.0 (data not shown), suggesting that the abnormalities are not directly due to impaired left-right patterning.

![Growth retardation of visceral organs in *Fam60a*^--/--^ mice.\
(**A--C**) Whole embryos and the indicated organs of WT (*Fam60a^+/+^*, (**A**) and *Fam60a*^--/--^ (**B** and **C**) mice at E13.5. Scale bars, 1 mm. (**D--F**) Sections of the heart of WT (**D**) or *Fam60a*^--/--^ (**E** and **F**) embryos at E13.5 stained with hematoxylin-eosin. The mutant embryos manifest ventricular septum defects (red arrows). Scale bar, 500 µm. (**G**) Expression of *Fam60a* in E13.5 heart was examined by whole-mount in situ hybridization. (**H** and **I**) *Fam60a*^--/--^ and WT embryos, respectively, at E9.5. The mutant embryos show overall growth retardation as well as shortening of the outflow tract (red bars) and a severe neural tube defect. Scale bars, 1 mm. See also [Figure 3---figure supplement 1 to 4](#fig3s1){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}.\
10.7554/eLife.36435.014Figure 3---source data 1.Numerical data of [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}.\
10.7554/eLife.36435.015Figure 3---source data 2.Numerical data of [Figure 3---figure supplement 4I](#fig3s4){ref-type="fig"}.](elife-36435-fig3){#fig3}

The *Fam60a*^--/--^ embryos already showed morphological abnormalities including growth retardation as well as cardiac (shortening of the outflow tract) and neural tube defects at E9.5 ([Figure 3H and I](#fig3){ref-type="fig"}). Given that most of the mutant embryos manifested growth retardation, we examined the rate of cell proliferation in various tissues of embryos at E9.0 to E9.5 by labeling with bromodeoxyuridine (BrdU) and counting of BrdU-positive cells ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}, [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}). The extent of cell proliferation was significantly reduced in the septum transversum, secondary heart field (SHF), and proepicardium, whereas it was unaffected in the heart ventricle and slightly increased in the neural tube, of *Fam60a*^--/--^ embryos compared with control embryos. Given that the outflow tract is derived from SHF cells ([@bib4]) and that *Fam60a* is expressed in SHF-derived regions of WT embryos ([Figure 3G](#fig3){ref-type="fig"}), the reduced proliferation rate of SHF cells may give rise to the shortening of the outflow tract and subsequent right ventricle hypoplasia apparent in the mutant embryos. These results thus suggested that *Fam60a* is required for cell proliferation and organogenesis in mouse embryos.

Fam60a is recruited to promoter regions and regulates gene expression {#s2-4}
---------------------------------------------------------------------

Given that the Sin3a-Hdac complex is thought to repress gene expression by binding to promoter regions, we examined the global gene expression pattern in *Fam60a*^--/--^ embryos by RNA-sequencing (RNA-seq) analysis. Comparison of *Fam60a*^--/--^ and WT embryos at E9.5 revealed that the expression of 558 genes was up-regulated and that of 172 genes was down-regulated in the mutant embryos ([Figure 4A and B](#fig4){ref-type="fig"}, [Figure 4---source datas 1](#fig4sdata1){ref-type="supplementary-material"} and [2](#fig4sdata2){ref-type="supplementary-material"}). Gene ontology analysis revealed that the expression of genes related to the response to nutrients or to extracellular matrix organization was increased, whereas that of those related to lipid biosynthesis was decreased, in the mutant embryos ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These data suggested that Fam60a regulates gene expression in both a negative and positive manner, but predominantly in a negative manner, in E9.5 embryos.

![Altered gene expression profile in *Fam60a*^--/--^ embryos.\
(**A**) Venn diagram showing the overlap between Fam60a target genes identified by ChIP-seq analysis and genes whose expression was up- or down-regulated in *Fam60a*^--/--^ embryos at E9.5 as revealed by RNA-seq analysis. (**B**) Fold change in RNA-seq values for genes that were differentially expressed in E9.5 *Fam60a*^--/--^ relative to WT embryos and which were also found to bind Fam60a-Venus in the TSS region by the ChIP-seq analysis. Data are means ± s.d. for three embryos. (**C**) Validation of RNA-seq data by RT-qPCR analysis for E9.5 WT and *Fam60a*^--/--^ embryos. Data are means ± s.d. for five independent experiments. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001 (Student's unpaired *t* test). See also [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"} and [2](#fig4s2){ref-type="fig"}.\
10.7554/eLife.36435.019Figure 4---source data 1.List of target genes of *Fam60a*.\
10.7554/eLife.36435.020Figure 4---source data 2.Numerical data of [Figure 4B](#fig4){ref-type="fig"}.\
10.7554/eLife.36435.021Figure 4---source data 3.Numerical data of [Figure 4C](#fig4){ref-type="fig"}.\
10.7554/eLife.36435.022Figure 4---source data 4.Numerical data of [Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}.\
10.7554/eLife.36435.023Figure 4---source data 5.Numerical data of [Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}.\
10.7554/eLife.36435.024Figure 4---source data 6.Numerical data of [Figure 4---figure supplement 2D](#fig4s2){ref-type="fig"}.](elife-36435-fig4){#fig4}

We also performed chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) analysis with E9.5 *Fam60a::Venus* transgenic embryos and antibodies to GFP to identify Fam60a binding sites in the genome. The Fam60a-Venus fusion protein encoded by this transgene was able to rescue the defects of *Fam60a* mutant mice ([Figure 1---figure supplement 1B and C](#fig1s1){ref-type="fig"}), suggesting that it is fully functional. Approximately 17,000 and 14,000 peaks were detected in two independent experiments (ChIP-seq1 and ChIP-seq2, respectively), with \~80% of the peaks being localized at gene loci, in particular in the vicinity of transcription start sites (TSSs) ([Figure 5A and B](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}, [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). This distribution pattern was highly similar to that previously determined for Sin3a ([@bib3]). Co-immunoprecipitation analysis of E10.5 transgenic embryos revealed that Fam60a-Venus interacts with Ing2 ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}), a protein that binds to Lys^4^-trimethylated histone H3 (H3K4me3), suggesting that Fam60a is recruited predominantly to the promoters of transcribed genes. Examination of the TSS region (between --3 kb and +3 kb relative to the TSS) of all genes resulted in the identification of 7989 genes that reproducibly showed at least one Fam60a binding site in this region ([Figure 5C](#fig5){ref-type="fig"}), suggesting that these genes may be directly regulated by Fam60a.

![Genome-wide localization of Fam60a to gene promoters.\
(**A**) Average binding profile for Fam60a-Venus at the TSS region of all genes with binding peaks identified by ChIP-seq analysis of E9.5 transgenic embryos with antibodies to GFP. Distance is expressed relative to the TSS. (**B**) Peak distribution for ChIP-seq analysis as in (**A**). About 80% of peaks were localized to gene loci. UTR, untranslated region. (**C**) Venn diagram showing the overlap in Fam60a target genes (those with binding peaks within ±3 kb of the TSS) for two independent ChIP-seq analyses (ChIP-seq1 and ChIP-seq2). (**D**) ChIP-qPCR analysis of the binding of Fam60a-Venus and Sin3a to the TSS regions of the indicated genes in E9.5 transgenic and WT embryos, respectively. The pale blue and orange bars represent IgG controls for antibodies to GFP and to Sin3a, respectively. Data are expressed as percentage of input and are means ± s.d. for three independent experiments. *Actb* was examined as a positive control. (**E**) Examples of Fam60a-Venus ChIP-seq results for E9.5 *Fam60a-Venus* embryos. ChIP-seq1 and ChIP-seq2 were both performed with antibodies to GFP. Peaks around the TSS are shown for four Fam60a target genes, with red arrows indicating the direction of transcription. See also [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"} and [2](#fig5s2){ref-type="fig"}.\
10.7554/eLife.36435.028Figure 5---source data 1.List of target genomic regions identified by ChIP-seq analysis.\
10.7554/eLife.36435.029Figure 5---source data 2.Numerical data of [Figure 5D](#fig5){ref-type="fig"}.\
10.7554/eLife.36435.030Figure 5---source data 3.Numerical data of [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}.](elife-36435-fig5){#fig5}

Among the 558 up-regulated and 172 down-regulated genes identified in *Fam60a*^--/--^ embryos, 245 and 45 genes, respectively, had at least one Fam60a binding peak in the TSS region ([Figure 4A](#fig4){ref-type="fig"}). Given that 74% (127/172) of the down-regulated genes lacked a Fam60a binding site in this region, the change in expression of most of the down-regulated genes was likely due to a secondary effect of Fam60a loss. We selected for further analysis 18 genes from the 290 (245 + 45) identified genes on the basis of their large fold change in expression in the mutant embryos as revealed by RNA-seq ([Figure 4B](#fig4){ref-type="fig"}). Reverse transcription and quantitative polymerase chain reaction (RT-qPCR) analysis confirmed significant differences in expression level for at least six of these putative Fam60a target genes between WT and *Fam60a*^--/--^ embryos at E9.5, with the expression of *Leng9*, *Adhfe1*, *Mxd3*, *Dchs1*, and *Nagk* being up-regulated and that of *Gt(ROSA)26Sor* being down-regulated in the mutant ([Figure 4C](#fig4){ref-type="fig"}, [Figure 4---source data 3](#fig4sdata3){ref-type="supplementary-material"}). The expression of some of these up-regulated genes (such as *Leng9*, *Dchs1*, and *Nagk*) was also increased in *Fam60a*^--/--^ ES cells compared with control ES cells ([Figure 4---figure supplement 2A and B](#fig4s2){ref-type="fig"}, [Figure 4---source data 4](#fig4sdata4){ref-type="supplementary-material"}). ChIP-qPCR analysis for three of the up-regulated genes (*Adhfe1*, *Nagk*, *Dchs1*) also revealed the association of their promoter regions with Fam60a-Venus and Sin3a in E9.5 transgenic and WT embryos, respectively ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---source data 2](#fig5sdata2){ref-type="supplementary-material"}). The Fam60a binding peaks identified by ChIP-seq analysis in the TSS regions of *Adhfe1*, *Nagk*, and *Dchs1* are shown in [Figure 5E](#fig5){ref-type="fig"}. Although the Sin3a-Hdac complex possesses histone-deacetylating activity, the level of Lys^9^-acetylated histone H3 (AcH3K9) at the promoter regions of Fam60a target genes (*Adhfe1*, *Nagk*, *Dchs1*) did not differ between WT and *Fam60a*^--/--^ embryos ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}, [Figure 5---source data 3](#fig5sdata3){ref-type="supplementary-material"}). However, similar analysis with *Fam60a*^--/--^ ES cells revealed that the level of AcH3K9 at the promoter regions of three such genes (*Leng9*, *Dchs1*, *Nagk*) was increased ([Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}, [Figure 4---source data 5](#fig4sdata5){ref-type="supplementary-material"}).

Association of Fam60a with DNA methylation and Tet {#s2-5}
--------------------------------------------------

We examined the molecular phylogeny of *Fam60a* with a sequence data set containing invertebrate homologs as well as a paralog, designated *Fam60b* ([Figure 6A](#fig6){ref-type="fig"}). The phylogenetic tree revealed the gene duplication event that gave rise to *Fam60a* and *Fam60b* in the early vertebrate lineage before the radiation of jawed vertebrates, likely during the well-studied genome expansion (2R-WGD, two-round whole genome duplication) that occurred in this period. It also highlighted the origin of the preduplication ortholog *Fam60* in the early metazoan era. Analysis of the families of genes encoding Sin3, Tet, and Dnmt proteins as well as the presence or absence of DNA methylation in individual species suggested an association of Fam60a with DNA methylation, Tet, and Sin3 ([Figure 6B](#fig6){ref-type="fig"}). Fam60a proteins of \~220 amino acid residues were thus found in all vertebrates examined, and Fam60a orthologs were also detected in insects but not in nematodes or yeasts ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}) ([@bib41]). DNA methylation and Tet proteins are also conserved from humans to insects but not in nematodes or yeasts, whereas Sin3 is more widely conserved from yeasts to humans.

![Phylogenetic and functional relation between Fam60a and Tet1.\
(**A**) Molecular phylogeny of Fam60a and related proteins. The tree was inferred with the maximum-likelihood method and 99 amino acid residues. Bootstrap values are indicated at individual nodes. (**B**) Gene repertories for Fam60, Sin3, Tet, and Dnmt families. Black boxes indicate the presence of at least one phylogenetically validated ortholog, whereas white boxes indicate the absence of orthologs. 2R-WGD, two rounds of whole-genome duplication. The presence or absence of DNA methylation in individual species based on current knowledge ([@bib45]; [@bib52]) is also shown. (**C** and **D**) Fam60a inhibits Tet1 activity in NIH3T3 cells. Immunofluorescence staining of 5hmC and FLAG-Tet1 was performed for NIH3T3 cells expressing FLAG-Tet1 either together with Fam60a (**C**) or alone (**D**). The cells were analyzed 24 hr after the induction of FLAG-Tet1 expression by doxycycline administration. Nuclei were stained with 4\',6-diamidino-2-phenylindole (DAPI). Red arrows indicate cells positive for both 5hmC and FLAG immunoreactivity. White arrows indicate cells positive for FLAG but negative for 5hmC. (**E**) Plots of mean fluorescence intensity for 5hmC versus FLAG-Tet1 in cells expressing FLAG-Tet1 without (left) or with (right) Fam60a as in (**C**) and (**D**). (**F**) Proportion of FLAG-Tet1^+^ cells that were negative for 5hmC in experiments similar to that in (**C**) and (**D**). Data are means ± s.d. for three independent experiments. \*p\<0.05 (Student's unpaired *t* test). See also [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}.\
10.7554/eLife.36435.034Figure 6---source data 1.Numerical data of [Figure 6E](#fig6){ref-type="fig"}.\
10.7554/eLife.36435.035Figure 6---source data 2.Numerical data of [Figure 6F](#fig6){ref-type="fig"}.](elife-36435-fig6){#fig6}

The association of Fam60a with DNA methylation and Tet, together with the fact that the Sin3a-Hdac complex interacts with methylation-regulating proteins such as methylated CpG binding protein2 (MeCP2), Dnmt1, and Tet1 ([@bib30]; [@bib48]), suggested that Fam60a might regulate Tet-mediated DNA demethylation. We tested this possibility in NIH3T3 cells transfected with a doxycycline-inducible expression vector for FLAG epitope--tagged Tet1 and with either an expression vector for both Fam60a and Venus or the corresponding empty vector. Exposure of the transfected cells to doxycycline thus induced the expression of Tet1 in the absence or presence of that of Fam60a ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). In the absence of Fam60a, 83% of FLAG-Tet1^+^ cells were positive for 5hmC (that is, only 17% of FLAG-Tet1^+^ cells remained negative for 5hmC) at 24 hr after the administration of doxycycline, suggestive of the efficient conversion of 5mC to 5hmC by FLAG-Tet1. In the presence of Fam60a, however, 55% of FLAG-Tet1^+^ cells remained negative for 5hmC ([Figure 6C--F](#fig6){ref-type="fig"}, [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"} and [2](#fig6sdata2){ref-type="supplementary-material"}), suggesting that Fam60a might inhibit Tet1 activity. Recruitment of Tet1 to the promoter regions of Fam60a target genes (*Leng9*, *Dchs1*, *Nagk*) was not affected in *Fam60a*^--/--^ ES cells ([Figure 4---figure supplement 2D](#fig4s2){ref-type="fig"}, [Figure 4---source data 6](#fig4sdata6){ref-type="supplementary-material"}), suggesting that Fam60a negatively regulates Tet1 activity without affecting its recruitment to promoter regions.

Aberrant promoter hypomethylation in *Fam60a*^--/--^ mouse embryos {#s2-6}
------------------------------------------------------------------

Given that our results suggested that Fam60a inhibits Tet1 activity in cultured cells, we next determined whether DNA methylation is affected in *Fam60a*^--/--^ mouse embryos. Bisulfite sequencing of the promoter regions of *Nagk* and *Leng9* revealed little or no DNA methylation in WT or *Fam60a*^--/--^ embryos at E9.5 ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), even though our ChIP analyses showed that Fam60a-Venus was recruited to these promoter regions in transgenic embryos. In contrast, the promoter region of *Adhfe1* was found to be hypomethylated in *Fam60a*^--/--^ embryos, with a methylation level of 4 to 10% compared with a value of \~20% in WT embryos at E9.5 ([Figure 7](#fig7){ref-type="fig"}, [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}). This hypomethylation might have been due to reduced de novo DNA methylation or increased demethylation mediated by Tet. To distinguish between these possibilities, we examined methylation of the *Adhfe1* promoter at earlier developmental stages, given that de novo DNA methylation occurs predominantly before implantation. No significant difference in methylation was observed between WT and *Fam60a*^--/--^ embryos at E7.5, after which the methylation level of this promoter gradually decreased in the mutant embryos ([Figure 7](#fig7){ref-type="fig"}, [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}). These results suggested that impaired maintenance of methylation or increased demethylation is responsible for the hypomethylation of the *Adhfe1* promoter in *Fam60a*^--/--^ embryos, consistent with our observation that Fam60a inhibited Tet1 activity in cultured cells. Providing further support for this notion, hydroxymethyl DNA immunoprecipitation (hMeDIP) analysis revealed 5hmC deposition at almost all Fam60a target gene promoters examined in WT embryos ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}, [Figure 7---source data 2](#fig7sdata2){ref-type="supplementary-material"}). Hypomethylation was not detected at the imprinting control regions of *Kcnq1ot1* or *Peg3* in *Fam60a*^--/--^ embryos ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}). Together, these findings suggested that Fam60a regulates Tet-mediated demethylation at a subset of gene promoters.

![Methylation status of the *Adhfe1* promoter during development of WT and *Fam60a*^--/--^ mouse embryos.\
(**A**) Methylation pattern at the *Adhfe1* promoter in representative WT and *Fam60a*^--/--^ embryos at the indicated developmental stages as revealed by bisulfite sequencing. Closed and open circles indicate methylated and nonmethylated CpG sites, respectively. Arrows indicate the TSS of *Adhfe1*. (**B**) Methylation frequency at the *Adhfe1* promoter determined as in (**A**) for three or four individual embryos of each genotype at each developmental stage. The p value was determined with Student's unpaired *t* test. See also [Figure 7---figure supplement 1 to 3](#fig7s1){ref-type="fig"}.\
10.7554/eLife.36435.040Figure 7---source data 1.Numerical data of [Figure 7B](#fig7){ref-type="fig"}.\
10.7554/eLife.36435.041Figure 7---source data 2.Numerical data of [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}.](elife-36435-fig7){#fig7}

Differentially methylated regions in the genome of *Fam60a*^--/--^ embryos {#s2-7}
--------------------------------------------------------------------------

To verify the role of Fam60a in regulation of DNA methylation, we examined the methylation status of promoters, CpG islands, and CpG shores in the genome of *Fam60a*^--/--^ and WT embryos at E9.5. These target regions were captured, subjected to bisulfite conversion, and sequenced with a next-generation sequencer. The overall methylation level of CpG sites in the captured DNA was around 45% and showed a similar distribution pattern in both *Fam60a*^--/--^ and WT embryos ([Supplementary file 2](#supp2){ref-type="supplementary-material"}, [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}).

Given that genome-wide DNA methylation level did not appear to be affected by the absence of Fam60a, we first examined DNA methylation levels over Fam60a-bound promoters (\~8000 promoters) in the wild-type and *Fam60a*^--/--^ embryos. Hypomethylation was commonly observed at the Fam60a-binding regions, but there was no obvious difference in the profile between the wild-type and *Fam60a*^--/--^ embryos ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). We next examined if the DNA methylation level was affected in a subset of gene promoters, by focusing on differentially methylated regions (DMRs). 7245 DMRs were detected with average changes of DNA methylation 11.87 and 10.99% for hyper- and hypomethylated DMRs, respectively ([Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}). Among the 7245 DMRs detected, 3049 and 4196 regions were hyper- and hypomethylated, respectively, in *Fam60a*^--/--^ embryos, with 388 hypermethylated DMRs (12.7%) and 1257 hypomethylated DMRs (30.0%) being found to overlap with Fam60a binding regions ([Table 1](#table1){ref-type="table"}). Among the top 500 hyper- and hypomethylated DMRs showing the largest differences in methylation level between mutant and WT embryos, 83 of the hypermethylated DMRs (16.6%) and 254 of the hypomethylated DMRs (50.8%) contained Fam60a binding sites ([Table 1](#table1){ref-type="table"}), suggestive of a preferential association of Fam60a binding sites with hypomethylated DMRs. The promoter of *Adhfe1*, which was found to be hypomethylated in *Fam60a*^--/--^ embryos ([Figure 7](#fig7){ref-type="fig"}), was included in the top 500 hypomethylated DMRs ([Figure 8---source data 1](#fig8sdata1){ref-type="supplementary-material"}).

10.7554/eLife.36435.042

###### The number of hyper- and hypomethylated DMRs overlapping with ChIP-seq peaks.

Relation between DMRs and Fam60a binding site for E9.5 embryos. Methyl-seq data were obtained for three *Fam60a*^--/--^ and three WT embryos, and ChIP-seq data were obtained for ChIP-seq1 and ChIP-seq2 experiments. The number of ChIP-seq peaks that overlap with all or the top 500 hyper- and hypomethylated DMRs are shown.

  Data set                                       Total DMRs   Direction     DMRs         Overlap with ChIP-seq peaks   
  ---------------------------------------------- ------------ ------------- ------------ ----------------------------- -----------
  3 embryos (triplicates) (mean Diff \>= 0.05)   7245         Hyper         3049         388 (12.7)                    83 (16.6)
  Hypo                                           4196         1257 (30.0)   254 (50.8)                                 

We next examined the positions of the top 500 hypermethylated and top 500 hypomethylated DMRs in the genome. The distributions of these two types of region differed, with hypermethylated DMRs being preferentially located in exonic regions of genes at 5 to 50 kb downstream of the TSS ([Figure 8A and C](#fig8){ref-type="fig"}), whereas most hypomethylated DMRs were located in intronic regions at 0 to 5 kb downstream of the TSS ([Figure 8B and D](#fig8){ref-type="fig"}). The distribution pattern of hypomethylated DMRs ([Figure 8B](#fig8){ref-type="fig"}) was similar to that of Fam60a binding sites ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). These data thus suggested that Fam60a is associated with DNA methylation status in mouse embryos.

![Differentially methylated regions (DMRs) in *Fam60a*^--/--^ embryos.\
(**A** and **B**) Distribution of the top 500 hyper- and hypomethylated DMRs, respectively, among various genomic features. (**C** and **D**) Genomic position profile for the top 500 hyper- and hypomethylated DMRs, respectively, relative to the nearest TSSs. Note that the total number exceeds 500 because TSSs on both strands, in the vicinity of a DMR, are counted. See also [Figure 8---figure supplements 1](#fig8s1){ref-type="fig"} and [2](#fig8s2){ref-type="fig"} and [Supplementary file 2](#supp2){ref-type="supplementary-material"}.\
10.7554/eLife.36435.047Figure 8---source data 1.List of hypo- and hypermethylated DMRs.The DMRs are ordered by the column areaStat, which is the sum of the t-statistics of CpGs. Note that *Adhfe1* is included in the top 500 hypomethylated DMRs.](elife-36435-fig8){#fig8}

Discussion {#s3}
==========

*Fam60a* is expressed ubiquitously during mouse embryonic development until at least E9.5, after which its expression gradually becomes restricted to a subset of cells, including those engaged in proliferation. In the adult mouse, *Fam60a* is expressed in stem cells located in intestinal crypts, suggesting that its expression may be associated with differentiation potential. Consistent with this notion, *Fam60a* knockout mice manifest growth retardation in visceral organs. Gene ontology analysis revealed that genes whose expression is dysregulated in *Fam60a*^--/--^ embryos include those related to the response to nutrients, extracellular matrix organization, and lipid biosynthesis, suggesting that disruption of these processes may contribute to the retardation of organ growth apparent in the mutant embryos.

A search for Fam60a-interacting proteins identified the Sin3a-Hdac transcriptional corepressor complex. The stoichiometry of Fam60a and components of this complex recovered in immunoprecipitates ([Figure 1](#fig1){ref-type="fig"}) suggested that most Fam60a in a given cell is associated with the complex. Fam60a may therefore function in association with the Sin3a-Hdac complex. Whereas Sin3a knockout mice die during embryogenesis around the time of implantation ([@bib27]), *Fam60a*^--/--^ embryos develop until later stages. It is thus possible that Sin3a has functions independent of Fam60a, including functions in multiple protein complexes, or that the earlier defects of Sin3a knockout mice are due to the lack of this protein in oocytes. Fam60a was recently shown to be a core subunit of a variant Sin3a complex in ES cells that includes Tet1 and Ogt ([@bib43]).

In general, the Sin3a-Hdac complex is thought to repress gene expression via histone deacetylation. However, this complex can also facilitate transcriptional activation in a manner dependent on cellular context ([@bib44]; [@bib17]). Indeed, we found that the expression of many genes was either up-regulated or down-regulated in *Fam60a*^--/--^ embryos. Fam60a may therefore contribute not only to the transcriptional corepressor activity of the Sin3a-Hdac complex but also to its promotion of transcriptional activation. Fam60a likely does not serve as a simple regulator of Hdac activity, given that the level of histone acetylation at Fam60a target gene promoters did not differ between WT and *Fam60a*^--/--^ embryos.

Phylogenetic analysis revealed a wide taxonomic distribution of the ancestral *Fam60* gene in eumetazoans and a duplication of this gene during early vertebrate evolution that gave rise to *Fam60a* and *Fam60b* paralogs. The absence of *Fam60* and *Tet* genes as well as of DNA methylation in both *Caenorhabditis elegans* and yeasts suggests that Fam60a may contribute to Sin3a function related to DNA methylation and Tet. Consistent with this possibility, Sin3a is known to interact with MeCP2, Dnmt1, and Tet1 ([@bib30]; [@bib48]). Of note, Tet proteins play a role in demethylation of evolutionarily conserved gene enhancers during the phylotypic period of early development ([@bib2]). *Adhfe1*, whose promoter was found to be hypomethylated in *Fam60a*^--/--^ embryos, appears to be a typical gene regulated by Fam60a and Tet activity. Expression of *Adhfe1* is thus normally repressed because of the methylation of its promoter that results from Fam60a-mediated inhibition of Tet activity, but it is up-regulated in *Fam60a*^--/--^ embryos because of the promoter hypomethylation that results from the absence of Fam60a. Other genes whose expression was up-regulated in *Fam60a*^--/--^ embryos (such as *Leng9* and *Nagk*) showed almost no DNA methylation in their promoter regions in either WT or mutant embryos, even though Fam60a-Venus was efficiently recruited to these promoters in transgenic embryos. In addition to functioning as DNA demethylases, Tet proteins associate with Sin3a-Hdac and act as transcriptional repressors in a manner independent of their demethylating activity ([@bib48]; [@bib53]). Up-regulation of genes such as *Leng9* and *Nagk* in *Fam60a*^--/--^ embryos may thus be due to the lack of the latter function of Tet proteins.

A genome-wide search for Fam60a binding sites revealed that Fam60a is recruited to gene promoter regions that overlap with CpG islands. In general, such CpG island promoters of transcriptionally active genes are enriched in H3K4me3. Consistent with the genomic localization of Fam60a, we found that Fam60a interacts with Ing2, which is known to bind to H3K4me3 ([@bib11]). Tet proteins interact with Sin3a and are thought to localize to CpG island promoters in order to maintain the CpG islands unmethylated, with such promoters often being marked with H3K4me3. These observations suggest that Fam60a is localized mostly to transcribed gene promoters, where it regulates the level of gene expression both negatively and positively via Sin3a and Tet.

How might Fam60a regulate Tet activity? It may inhibit dioxygenase enzymatic activity or impair recruitment of Tet to DNA. In this regard, PGC7 (also known as Stella) protects the female pronucleus from Tet3-dependent conversion of 5mC to 5hmC in mouse zygotes as well as inhibits the binding of Tet3 to chromatin in mouse ES cells ([@bib29]). Fam60a may similarly affect the binding of Tet to chromatin, although this is unlikely given that recruitment of Tet1 to Fam60a target genes was not affected in *Fam60a*^--/--^ ES cells. Alternatively, Fam60a may physically interact with Tet proteins and inhibit their activity. However, given that Tet proteins were not identified in our search for Fam60a-interacting proteins, it is unlikely that Fam60a directly interacts with Tet. Further characterization of the mechanisms by which Fam60a affects the function of Sin3a and Tet should provide new insight into gene regulation during embryogenesis.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\        Designation                    Source or reference        Identifiers                                                       Additional information
  or resource                                                                                                                                                
  ------------------------------ ------------------------------ -------------------------- ----------------------------------------------------------------- -------------------------------
  Gene (*mus musculus*)          fam60a                         NA                         NCBI Gene: 56306                                                  also known as SINHCAF

  Gene (*mus musculus*)          Tet1                           NA                         NCBI Gene: 52463                                                  

  Strain, strain background\     ICR                            charles river                                                                                
  (*mus musculus*)                                                                                                                                           

  Strain, strain background\     C57BL/6J                       charles river                                                                                
  (*mus musculus*)                                                                                                                                           

  Strain, strain background\     129                            charles river                                                                                
  (*mus musculus*)                                                                                                                                           

  Strain, strain background\     B6C3F1/Crl                     charles river                                                                                
  (*mus musculus*)                                                                                                                                           

  Genetic reagent (EMCV)         internal ribosomal entry\      NA                                                                                           
                                 site (IRES)-βgeo                                                                                                            

  Genetic reagent\               loxP                           NA                                                                                           
  (P1 phage)                                                                                                                                                 

  Genetic reagent\               FRT                            NA                                                                                           
  (P1 phage)                                                                                                                                                 

  Genetic reagent\               CAG-Flpe                       PMID: 16651697                                                                               
  (*Saccharomyces cerevisiae*)                                                                                                                               

  Genetic reagent\               CAG-Cre                        PMID: 9268708                                                                                
  (P1 phage)                                                                                                                                                 

  Genetic reagent\               Fam60a-Venus                   this paper                                                                                   
  (Aequorea victoria)                                                                                                                                        

  Genetic reagent\               Fam60a-CreERT2                 this paper                                                                                   
  (P1 phage)                                                                                                                                                 

  Cell line (*mus musculus*)     P19                            PMID:7056443                                                                                 

  Cell line (*mus musculus*)     NIH3T3 Tet-On 3G               Clontech                   631197                                                            

  Antibody                       Antibody to Fam60a\            this paper                                                                                   1/1000 dilution for IHC or WB
                                 (α-E15W) (rabbit polyclonal)                                                                                                

  Antibody                       anti-GFP\                      MBL                        Code No.598\                                                      10 µl for IP,\
                                 (rabbit polyclonal)                                       RRID: [AB_591819](https://scicrunch.org/resolver/AB_591819)       1/2000 dilution for IF

  Antibody                       control Rabbit IgG             Kamiya Biomedical          PC-124                                                            used for IP control

  Antibody                       control Rabbit IgG             Thermo Fisher Scientific                                                                     used for IP control

  Antibody                       anti-HDAC1\                    abcam                      ab31263\                                                          this product is discontinued\
                                 (mouse monoclonal)                                        RRID: [AB_732774](https://scicrunch.org/resolver/AB_732774)       by abcam

  Antibody                       anti-FLAG\                     Sigma-Aldrich              F3165\                                                            1/2000 for IF
                                 (mouse monoclonal)                                        RRID: [AB_259529](https://scicrunch.org/resolver/AB_259529)       

  Antibody                       anti-HDAC2\                    abcam                      ab7029\                                                           1/1000 dilution for WB
                                 (rabbit polyclonal)                                       RRID: [AB_305706](https://scicrunch.org/resolver/AB_305706)       

  Antibody                       anti-Sin3a\                    Santa Cruz\                sc-994\                                                           1/1000 dilution for WB
                                 (rabbit polyclonal)            Biotechnology              RRID: [AB_2187760](https://scicrunch.org/resolver/AB_2187760)     

  Antibody                       anti-Ing2\                     abcam                      ab109504\                                                         1/2000 dilution for WB
                                 (rabbit polyclonal)                                       RRID: [AB_10861294](https://scicrunch.org/resolver/AB_10861294)   

  Antibody                       anti-BrdU\                     BD bioscience              347580\                                                           1/200 dilution for IHC
                                 (mouse monoclonal)                                        RRID: [AB_10015219](https://scicrunch.org/resolver/AB_10015219)   

  Antibody                       anti-5hmC\                     active motif               39769\                                                            1/2000 dilution for IF
                                 (rabbit polyclonal)                                       RRID: [AB_10013602](https://scicrunch.org/resolver/AB_10013602)   

  Antibody                       anti-Histone H3K9ac\           active motif               39917\                                                            used for ChIP assay
                                 (rabbit polyclonal)                                       RRID: [AB_2616593](https://scicrunch.org/resolver/AB_2616593)     

  Antibody                       anti-RbAp46/48\                active motif               39199\                                                            1/2000 dilution for WB
                                 (rabbit polyclonal)                                       RRID: [AB_2615007](https://scicrunch.org/resolver/AB_2615007)     

  Recombinant\                   pTRE3G-FLAG-Tet1               this paper                                                                                   
  DNA reagent                                                                                                                                                

  Recombinant\                   pEF-BOS-Fam60a-IRES-Venus      this paper                                                                                   
  DNA reagent                                                                                                                                                

  Recombinant\                   pEF-BOS                        PMID: 1698283                                                                                
  DNA reagent                                                                                                                                                

  Peptide, recombinant\          E15W                           this paper                                                                                   for the rise of\
  protein                                                                                                                                                    Anti-Fam60a antibody

  Peptide, recombinant\          recombinant\                   abcam                      ab85191                                                           
  protein                        GFP protein                                                                                                                 

  Commercial assay or kit        EpiTect Bisulfite Kit          Qiagen                     ID: 59104                                                         

  Commercial assay or kit        PrimeScript RT Reagent Kit\    Takara                     RR047A                                                            
                                 with gDNA Eraser                                                                                                            

  Commercial assay or kit        SOLiD Total RNA-Seq Kit        Life Technologies          4445374                                                           

  Commercial assay or kit        SureSelect Methyl-Seq\         Agilent Technologies       931052                                                            
                                 Target Enrichment System                                                                                                    

  Commercial assay or kit        EZ Methylation-Gold Kit        Zymo Research                                                                                

  Chemical compound,\            BS3                            Thermo Fisher Scientific   Prod\#21580                                                       for antibody conjugation\
  drug                                                                                                                                                       to dynabeads

  Chemical compound,\            Doxycycline hyclate            Sigma-Aldrich              D9891                                                             
  drug                                                                                                                                                       

  Chemical compound,\            tamoxifen                      Sigma-Aldrich              T5648-1G                                                          dissolved in corn oil
  drug                                                                                                                                                       

  Software, algorithm            LifeScope software             Applied Biosystem                                                                            

  Software, algorithm            MACS                           PMID: 18798982                                                                               

  Software, algorithm            CEAS                           PMID: 19689956                                                                               

  Software, algorithm            QUMA                           PMID: 18487274                                                                               

  Software, algorithm            bowtie2                        PMID: 22388286                                                                               

  Software, algorithm            Bismark                        PMID: 21493656                                                                               

  Software, algorithm            Samtools                       PMID: 19505943                                                                               

  Software, algorithm            Picard toolkit                 Broad Institute                                                                              

  Software, algorithm            methylKit program              PMID: 23034086                                                                               

  Software, algorithm            BSseq program                  PMID: 23034175                                                                               

  Software, algorithm            bedtools                       PMID: 20110278                                                                               

  Software, algorithm            GREAT                          PMID: 20436461                                                                               

  Software, algorithm            aLeaves                        PMID: 23677614                                                                               

  Software, algorithm            MAFFT                          PMID: 23329690                                                                               

  Software, algorithm            trimAl                         PMID: 19505945                                                                               

  Software, algorithm            RAxML                          PMID: 24451623                                                                               
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mice {#s4-1}
----

*Fam60a*^βgeo^, a mutant allele of *Fam60a* in which an internal ribosome entry site (IRES)--βgeo cassette and a loxP site are inserted in intron 4 and intron 1, respectively, was generated by gene targeting in mouse ES cells ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). A *Fam60a*^flox^ allele was subsequently generated with the use of the *CAG-Flpe* transgene ([@bib18]), and a *Fam60a*^--^ allele lacking exons 2 to 4 was generated with the use of the *CAG-Cre* transgene ([@bib35]). Both *Fam60a*^βgeo^ and *Fam60a*^--^ alleles are functionally null. Mutant mice were maintained on the 129/C57B6 mixed background. PCR primers for genotyping were Fam60a-5A (5′-ATATGCTGCTAGGTGCCACAG-3′), Fam60a-3A (5′-TTCTCTACTCCATAGCACAGG-3′), and Fam60a-3C (5′-CTACTGTGGTCACAAGCAGAC-3′). A BAC transgene (*Fam60a::Venus*) encoding a Fam60a-Venus fusion protein was constructed from mouse BAC clone RP23-100A22 with the use of a BAC recombination system ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}) ([@bib6]). The Fam60a-Venus protein, in which Venus is fused to the COOH-terminus of Fam60a, is functional, given that the transgene is able to rescue the phenotype of *Fam60a* mutant mice ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). A BAC transgene (*Fam60a-CreERT2*) was constructed by inserting CreERT2 into the *Fam60a* BAC clone.

Cell line origin and authentication {#s4-2}
-----------------------------------

P19 embryonal carcinoma cell line ([@bib26]) is a gift from Michael McBurney (University of Ottawa). NIH3T3 Tet-On 3 G cell line (631197, Clontech) was purchased from Clontech, Takara-bio (Kyoto, Japan).

Identification of Fam60a-interacting proteins {#s4-3}
---------------------------------------------

E10.5 embryos harboring the *Fam60a::Venus* transgene were recovered in PBS for the preparation of nuclear extracts. The embryos were passed through a 70 µm cell strainer with a plunger, and the cells were allowed to swell by incubation in buffer A (10 mM Hepes-KOH (pH 7.9), 10 mM KCl, 1.5 mM MgCl~2~, 0.1 mM EGTA, 1 mM dithiothreitol, and Roche complete protease inhibitor cocktail) for 15 min on ice before homogenization with 20 strokes of a loose-fitting pestle in a Dounce homogenizer. Nonidet P-40 was then added to the homogenate at a final concentration of 0.1%, and another 20 strokes of the pestle were applied. The homogenate was centrifuged at 960 × *g* for 5 min at 4°C, and the resulting nuclear pellet was suspended and incubated for 3 hr at 4°C either in RIPA buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM dithiothreitol, and Roche complete protease inhibitor cocktail), in buffer C (20 mM Hepes-KOH (pH 7.9), 400 mM NaCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% Nonidet P-40, 1 mM dithiothreitol, and Roche complete protease inhibitor cocktail), or in nondenaturing lysis buffer containing Benzonase nuclease (20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 2 mM EGTA, 1.5 mM MgCl~2~, 10% glycerol, 1 mM dithiothreitol, Benzonase nuclease (125 U; 70,446--3, Novagen), and Roche complete protease inhibitor cocktail). The samples were centrifuged at 18,000 × *g* for 10 min at 4°C, and the resulting supernatants (nuclear extracts) were incubated with Dynal Protein G beads (Invitrogen) for 3 hr at 4°C. After removal of the beads, the extracts were divided into two halves. One half was incubated for 3 hr at 4°C with Dynal Protein G beads conjugated with antibodies to GFP, whereas the other half was incubated with identical antibody-conjugated beads that had been previously exposed to recombinant GFP (ab84191, Abcam) to mask the antigen binding site. Proteins that bound to the beads were eluted by incubation for 30 min at 37°C with 1 × SDS sample buffer not containing dithiothreitol. They were then fractionated by SDS-polyacrylamide gel electrophoresis and silver-stained. Target proteins were identified by liquid chromatography and tandem mass spectrometry with a nano-UPLC Q-TOF MS/MS system (SYNAPT G2, Waters).

Immunoprecipitation and immunoblot analysis {#s4-4}
-------------------------------------------

Nuclear extracts prepared from E10.5 embryos or undifferentiated P19 cells with RIPA buffer as described above were incubated for 3 hr at 4°C first with Dynal Protein G beads alone and then with antibody-conjugated beads. Proteins that bound to the antibody-conjugated beads were eluted by incubation for 30 min at 37°C with 1 × SDS sample buffer not containing dithiothreitol, fractionated by SDS-polyacrylamide gel electrophoresis, and transferred to a polyvinylidene difluoride membrane. The membrane was then subjected to immunoblot analysis with primary antibodies, horseradish peroxidase--conjugated secondary antibodies, and ECL Plus reagents (RPN2133, Amersham).

Lineage tracing {#s4-5}
---------------

Tamoxifen (6 mg; T5648, Sigma-Aldrich) in 1 ml of corn oil (C8267, Sigma-Aldrich) was administered orally to *Fam60a-CreERT2::ROSA26RlacZ* mice at the age of 8 weeks age. One, 3, or 5 days after tamoxifen administration, mice were killed and the duodenum was removed and then fixed overnight at 4°C in phosphate-buffered saline (PBS) containing 1% paraformaldehyde, 0.2% glutaraldehyde, and 0.02% Nonidet P-40. Expression of the *lacZ* transgene was detected by staining with X-gal as described previously ([@bib33]).

In situ hybridization and histology {#s4-6}
-----------------------------------

Embryos were dissected in PBS and fixed with 4% paraformaldehyde. In situ hybridization was performed with whole-mount preparations ([@bib36]) or sections ([@bib51]). The 3′untranslated region of *Fam60a* was used as a probe for in situ hybridization. For histological analysis, embryos were fixed with 4% paraformaldehyde, dehydrated, and embedded in paraffin. Serial sections (thickness, 7 µm) were stained with hematoxylin-eosin according to standard procedures.

Antibodies {#s4-7}
----------

Antibodies to Fam60a (α-E15W) were generated in rabbits by injection of a synthetic peptide corresponding to the COOH-terminal region of the mouse protein (EEQGPAPLPISTQEW) and were affinity-purified. Additional antibodies included control rabbit IgG (Kamiya Biomedical or Thermo Fisher Scientific), conformation-specific mouse monoclonal antibodies to rabbit IgG (\#3678, Cell Signaling) that can avoid detection of denatured rabbit IgG used for immunoprecipitation, as well as rabbit polyclonal antibodies to GFP (598, MBL International), to Hdac1 (ab31263, Abcam), to FLAG (F3165, Sigma-Aldrich), to Hdac2 (ab7029, Abcam), to Sin3a (sc-994, Santa Cruz Biotechnology), to Ing2 (ab109504, Abcam), to RbAp46/48 (39199, Active Motif), to AcH3K9 (39917, Active Motif), to BrdU (347580, BD Biosciences), and to 5hmC (39769, Active Motif). Mouse monoclonal antibodies to FLAG for immunostaining were obtained from Sigma.

Immunostaining of embryos {#s4-8}
-------------------------

Cryosections were incubated overnight at 4°C with primary antibodies. Immune complexes were detected with horseradish peroxidase--conjugated secondary antibodies (ImmPRESS reagent, Vector labs) or Alexa Fluor 488--conjugated secondary antibodies (Molecular Probes). Nuclei were counterstained with 4\',6-diamidino-2-phenylindole (DAPI). Confocal images were acquired with a confocal microscope (Olympus FV1000D or Zeiss LSM510META).

BrdU incorporation assay {#s4-9}
------------------------

Pregnant mice were injected intraperitoneally with undiluted BrdU labeling reagent (RPN20LR, Amersham) at a dose of 1 ml per 100 g of body weight. Embryos were dissected 30 min after BrdU injection and were subjected to immunostaining of BrdU as previously described ([@bib37]) with the use of a Vectastain ABC Kit (Vector labs) and diaminobenzidine. The proliferation index was calculated as the percentage of cells positive for BrdU incorporation.

RT-qPCR analysis {#s4-10}
----------------

Total RNA was isolated from E9.5 embryos with the use of TRIzol reagent (15596026, Invitrogen), and portions of the RNA (1 in 20 µl) were subjected to RT with the use of a PrimeScript RT Reagent Kit with gDNA Eraser (RR047A, Takara). The resulting cDNA (corresponding to an RNA amount of 15, or 0.92 ng for β-actin qPCR) was subjected to real-time PCR analysis with the use of Power SYBR Green PCR Master Mix (4367659, Applied Biosystems). For quantitation of mRNAs, we established standard curves with serial dilutions of RNA of known concentrations. Data were normalized byβ-actin mRNA abundance. PCR primers (forward and reverse, respectively) were as follows: 5′-GGTCATCACTATTGGCAACG-3′ and 5′-ACGGATGTCAACGTCACACT-3′ for *Actb* (β-actin); 5′-TACCAGGGTAGCAACCCAAT-3′ and 5′-GGTTTCTGACAGCCCTCTTC-3′ for *Adhfe1*; 5′-CTGATTGAGGAGTTGAGGC-3′ and 5′-AGCCTACAGTTGGAGCCTG-3′ for *Nagk*; 5′-CTGACTTTTCGGTGGGCTACA-3′ and 5′-GGCGCAGAATGGCTCTTC-3′ for *Leng9*; 5′-GGCCTGCCTCCTTTAGTCTC-3′ and 5′-TGTCAGCATCTGTGGCTGTT-3′ for *Dchs1*; 5′-GCTCAGACTCAGACCAAGAG-3′ and 5′-TGCTGTGTGAGTAGCTGTGC-3′ for *Mxd3*; 5′-GGGGGAATGAGTGCTTGAAG-3′ and 5′-TCACCTGGACCTCCAAATGTC-3′ for *AA465934*; 5′-AAAGAGAAACTGCCAACGC-3′ and 5′-TATTCATACCTGGGCCGAAG-3′ for *2610020C07Rik*; 5′-GTAGGGGATCGGGACTCTGG-3′ and 5′-TCCTCAAGGAATGATCCGGC-3′ for *Gt(ROSA)26Sor*; and 5′-CAATTACAGAAGTGTGGGACT-3′ and 5′-CACCTTCCTCCCAGTTCTTT-3′ for *Acsl3*.

ChIP-seq and RNA-seq {#s4-11}
--------------------

E9.5 embryos harboring the *Fam60::Venus* transgene were recovered in PBS for ChIP with antibodies to GFP performed as previously described ([@bib16]). The isolated DNA was applied to ChIP-seq library construction with the use of a SOLiD Fragment Library Core Kit (PN 4464412, Life Technologies). Sequencing was performed with a SOLiD four instrument (Life Technologies). Sequenced reads were aligned to the mouse genome (mm9) with the use of LifeScope software (Applied Biosystems). Aligned peaks were called and BED and Wig files were generated with MACS version 1.4.1 ([@bib55]), and the files were visualized in the UCSC genome browser as custom tracks. The called peaks were filtered with the following criteria: false discovery rate (FDR) of ≤1% and fold enrichment of ≥2.0. To obtain a peak distribution and averaged peak profile around genes, we analyzed the filtered peaks with CEAS version 1.0.2. Genes with filtered peaks within ±3 kb of the TSS in UCSC RefGene were defined as Fam60a target genes.

For RNA-seq, E9.5 embryos were collected in PBS and stored in RNAlater (AM7020, Ambion) at --80°C. After genotyping with yolk sac DNA, RNA was isolated from WT and *Fam60a*^--/--^ embryos with the TRIzol reagent and mRNA was extracted twice with the use of a MicroPoly(A) Purist Kit (AM1922, Life Technologies). Library preparation was performed with the use of a SOLiD Total RNA-Seq Kit (4445374, Life Technologies). Three biological replicates were analyzed for each genotype. Libraries were labeled with distinct barcoding adapters. Sequencing was performed with a SOLiD4 instrument, and sequencing data were mapped to the mouse genome (mm9) with the use of LifeScope software. Differentially expressed genes were identified with the edgeR Bioconductor package. Transcripts with an FDR of \<0.01 were considered to be significantly up- or down-regulated.

Bisulfite sequencing {#s4-12}
--------------------

Genomic DNA was isolated from WT and *Fam60a*^--/--^ embryos according to standard procedures, and its concentration was determined by spectrophotometry. The DNA (500 to 1000 ng) was treated with bisulfite and purified with the use of an EpiTect Bisulfite Kit (59104, Qiagen) and was then subjected to PCR amplification with the following primer sets: 5′- ATTTAGTGGGGTTTTTGTTATTG-3′ (Adhfe1 Bis F1) and 5′-TATTTCTACACATAAACCCATAC-3′ (Adhfe1 Bis R1) for initial PCR and Adhfe1 Bis F1 and 5′-ACTAAACCACATTACACCATCC-3′ (Adhfe1 Bis R2) for seminested PCR; 5′-TGGAAGGAGGTTAAAGGATTAG-3′ (Leng9 Bis F1) and 5′-AAATTATCTAAACCCTACCCCC-3′ (Leng9 Bis R1); 5′-ATTTTTTTAGGAGTTTTAGTTGGGGTG-3′ (Nagk Bis F1) and 5′-CAACTCTACACAACTCTCCAAATTAAC-3′ (Nagk Bis R1); 5′-AGAGGGTGTATGTTGTAGAGTAGTTAGGTG-3′ (Peg3 Met11) and 5′-CATCCCATCCCCCTTTTCCAAACTCTAC-3′ (Peg3 Met12.1); and 5′-GTATTTAGTTTATTATGAGGAAGAGTTT-3′ (Kcnq1ot1 1F) and 5′-CAAAAACAACTCCAAAAAAACTATAAA-3′ (Kcnq1ot1 1R). The amplified fragments were separated by agarose gel electrophoresis and the target bands excised. DNA was recovered from the excised gel pieces with the use of a QIAquick Gel Extraction Kit (28706, Qiagen) and was then cloned into the pCRII vector with the use of a Dual Promoter TA Cloning Kit (K207020, Invitrogen). Sequenced fragments were analyzed with the QUMA tool (quantification tool for methylation analysis; <http://quma.cdb.riken.jp>).

Forced expression of Fam60a and FLAG-Tet1 {#s4-13}
-----------------------------------------

NIH3T3 Tet-On 3G fibroblasts (631197, Clontech) were seeded at \~80% confluence on 15-mm-diameter cover slips coated with 0.1% gelatin and placed in 24-well plates. The cells were cultured for at least 2 hr at 37°C in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and were then transfected for 24 hr with 125 ng of pTRE3G-FLAG-Tet1 (encoding FLAG-tagged mouse Tet1) with or without 250 ng of pEF-BOS-Fam60a-IRES-Venus (encoding mouse Fam60a and Venus) with the use of the Lipofectamine LTX reagent (15338500, Invitrogen). The cells transfected without or with pEF-BOS-Fam60a-IRES-Venus were also transfected with 375 or 125 ng, respectively, of the pEF-BOS empty vector. Expression of FLAG-Tet1 was induced by exposure of the cells to doxycycline (1 µg/ml) for 24 hr, after which the cells were fixed for 15 min with 4% paraformaldehyde in PBS, permeabilized for 15 min with 0.2% Triton X-100 in PBS, treated for 20 min with 2 M HCl, neutralized for 10 min with 100 mM Tris-HCl (pH 8.0), washed with PBS, and exposed for 1 hr to blocking buffer (1% bovine serum albumin and 0.1% Tween 20 in PBS), all at room temperature. The cells were then incubated overnight at 4°C with mouse monoclonal antibodies to FLAG (1:2000 dilution) and rabbit polyclonal antibodies to 5hmC (1:2000 dilution) in blocking buffer. Immune complexes were detected with Alexa Fluor 568-- or Alexa Fluor 647--conjugated secondary antibodies (Molecular Probes), respectively, and nuclei were stained with DAPI (250 ng/ml). The cells were mounted in ProLong Gold antifade reagent (P36930, Invitrogen), and images were acquired with a confocal microscope (Olympus FV1000D). The fluorescence intensity of 5hmC was plotted against that of FLAG. If FLAG fluorescence intensity was \>40, the cell was considered as FLAG-Tet1 positive; if 5hmC fluorescence intensity was \>30, the cell was considered as 5hmC positive.

ChIP-qPCR {#s4-14}
---------

ChIP was performed as described above, and the precipitated DNA was subjected to qPCR analysis with the following primers (forward and reverse, respectively): 5′-CTAGCCACGAGAGAGCGAAG-3′ and 5′-AGCTTCTTTGCAGCTCCTTC-3′ for *Actb*; 5′-GACCGGATTGGCTGTTAGTG-3′ and 5′-TAGGTGCCTCAGCAAGTGTG-3′ for *Adhfe1*; 5′-CTAGGAAGAAGCGGCAGACC-3′ and 5′-GGCGTCACAGTTGGAGATCA-3′ for *Leng9*; 5′-CTGAGATTCATGCACAAGGG-3′ and 5′-TATAGGAACCAAGGGCGTTC-3′ for *Nagk*; 5′-GCGAGGACACTCACTGACTC-3′ and 5′-AGTGTGTGGTGGTGCTTGAG-3′ for *Dchs1*; 5′-GTGACGACAACTCGCGTAC-3′ and 5′-AATGGCCCTAATGAGAGACG-3′ for *Mxd3*; 5′-TTGGGAATCCAGTGGAAACT-3′ and 5′-AGCCATGCACAAAGTTCTTG-3′ for *Acsl3*; 5′-CTGGAGTTGCAGATCACGAG-3′ and 5′-CCTTTCTGGGAGTTCTCTGC-3′ for *Gt(ROSA)26Sor*; 5′-TAAAGAGAAACTGCCAACGC-3′ and 5′ CTCATAGGACGTTCTGGCG 3′ for *2610020C07Rik*; and 5′-CTGTCCAAGACTGCGGAATG-3′ and 5′-CCTGAAGCCATCCTTGGTAG-3′ for *AA465934*. 

hMeDIP analysis {#s4-15}
---------------

E9.5 embryos were recovered in PBS and stored at --80°C. After genotyping, embryos were lysed overnight at 55°C in a solution containing 20 mM Tris-HCl (pH 8.0),

4 mM EDTA, 20 mM NaCl, 1% SDS, and proteinase K (0.4 mg/ml, Nacalai). They were then exposed for 30 min at 37°C to RNase A (5 mg/ml, Sigma) before purification of genomic DNA first by phenol-chloroform treatment and ethanol precipitation and then with the use of a QIAamp DNA Micro Kit (56304, Qiagen). The DNA was sheared with the use of a Bioruptor UCD-250 (Diagenode) (15 s on and 15 s off for 10 min at low power). Portions (500 ng) of the sheared DNA were denatured for 10 min at 98°C, placed on ice, and then incubated overnight at 4°C with rotation in 100 µl of hMeDIP buffer containing 20 mM Tris-HCl (pH 8.0), 2 mM EDTA, 150 mM NaCl, 1% Triton X-100, 4 µg of antibodies to 5hmC, and 1% bovine serum albumin. Dynal Protein G beads were then added to the samples to precipitate the antibody-DNA complexes, after which the beads were washed three times with hMeDIP wash buffer (20 mM Tris-HCl (pH 8.0), 2 mM EDTA, 300 mM NaCl, 1% Triton X-100, 0.1% SDS) and then treated overnight at 55°C with proteinase K in hMeDIP elution buffer (20 mM Tris-HCl (pH 8.0), 8 mM EDTA, 300 mM NaCl, 0.5% SDS). The eluted DNA was purified with the use of a QIAquick PCR Purification Kit (28106, Qiagen) and subjected to qPCR analysis with the primers described above for ChIP-qPCR.

Methyl-seq library construction {#s4-16}
-------------------------------

Libraries compatible with the Illumina platform were prepared from 3 µg of genomic DNA with the use of a SureSelect Methyl-Seq Target Enrichment System (Agilent Technologies). Genomic DNA was sheared at 4°C by focused ultrasonic disruption with a Focused-ultrasonicator E220 (Covaris) (duty factor, 10%; PIP, 175; cycles per burst, 200; time, 360 s). The fragmented DNA was end-repaired, adenylated at the 3′ end, and ligated to a methylated adapter. The prepared libraries were subjected to hybridization with the biotinylated SureSelect Methyl-Seq Capture Library (Agilent Technologies), which covers genomic regions of 109 Mb in total including GENCODE promoters; CpG islands, shores, and shelves; DNase I--hypersensitive sites; and RefGenes. Library molecules that overlapped the targeted regions were collected with streptavidin-conjugated beads and converted with bisulfite with the use of an EZ Methylation-Gold Kit (Zymo Research) before amplification by PCR. Further amplification was performed with the use of the SureSelect Methyl-Seq Indexing Primer (Agilent Technologies) to allow multiplexed sequencing on the Illumina platform.

Methyl-seq and detection of DMRs {#s4-17}
--------------------------------

The amplified libraries supplemented with 20% of a phiX sequencing control library were sequenced with an Illumina HiSeq 1500 instrument with 2 × 127 cycles in the Rapid Run Mode. Sequence reads were obtained with HiSeq Control Software (HCS) version 2.2.58 and Real-Time Analysis (RTA) version 1.18.64.0. The obtained paired-end reads were subjected to quality control with FastQC version 0.11.5 (<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>), and adapter sequences and low-quality reads were removed using Trim Galore! version 0.4.2 and with the parameters '-e 0.1 -q 30' (<http://www.bioinformatics.babraham.ac.uk/projects/trim_galore>). After the removal of phiX-derived reads with Bowtie2 version 2.3.0 ([@bib23]), the valid reads were mapped to the UCSC mm9 reference genome sequence using Bismark version 0.17.0 ([@bib20]) and with the parameters '\--bowtie2 -N 1 L 22 \--score_min L,-0.6,-0.6.' Before methylation calling at each CpG site, potential PCR duplicates were removed and only read-pairs from the expected strand (the original bottom strand of the reference genome sequence) were extracted with the use of Bismark and Samtools version 1.3.1 ([@bib25]), respectively. The on-bait coverage of mapped reads was calculated with CollectHsMetrics of the Picard package version 2.8.1 (<http://broadinstitute.github.io/picard>). Methylated CpG was identified using the bismark_methylation_extractor function of Bismark and with the parameter '\--cutoff 5.' To compare methylation profiles among libraries, we performed a hierarchical clustering analysis according to Ward's method with the use of the methylKit program version 1.0.0 ([@bib1]) in the Bioconductor package. For detection of DMRs in three mutant embryos compared with three WT embryos, we used BSseq version 1.10.0 ([@bib14]) in the Bioconductor package. After importation of the CpG report files of the Bismark output, the BSseq data were processed with the BSmooth algorithm for computation of smoothed methylation levels. The smoothed methylation data were selected for regions with a read coverage of at least five reads at the CpG sites in at least two of the three samples in both comparison groups. Comparison of the mutant and WT samples was then performed with t-statistics. DMRs were detected on the basis of the threshold 'qcutoff (low = 0.025, high = 0.975)' and were further narrowed down to those with a minimum of three CpG sites and mean methylation difference of ≥0.05. For examination of the relation between DMRs and Fam60a ChIP-seq peak regions, the peaks of the two ChIP-seq analyses were merged on the basis of their genomic locations and the merged peaks were then compared with DMRs with the use of bedtools version 2.26.0 (<http://bedtools.readthedocs.io>). Regions of overlap were characterized by statistical evaluation of peak enrichment at genome features such as promoters, exons, introns, untranslated regions (UTRs), and distal intergenic regions with the use of CEAS version 0.9.9.7 ([@bib39]), and plots of average profiles near TSSs were constructed with GREAT version 3.0.0 ([@bib28]). Methylation levels at imprinted genes and DMRs were visualized with the UCSC Integrative Genomics Viewer (IGV) version 2.3.72 ([@bib47]).

Molecular phylogenetics {#s4-18}
-----------------------

Amino acid sequences similar to that of human Fam60a were collected by aLeaves ([@bib21]), and the resultant sequence set was then modified to remove redundant sequences. The modified sequence set was subjected first to multiple alignment with the use of the program MAFFT v7.299b ([@bib19]) and with the option '-linsi' and then to trimming of unaligned and gapped sites with the program trimAl v1.4.rev15 ([@bib5]) with the options '-automated1' and '-nogaps' in order. The obtained sequence file was used to infer the maximum-likelihood tree with the program RAxML v8.2.8 ([@bib42]) according to the PROTCATWAG model and with 1000 bootstrap resamplings.

Data availability {#s4-19}
-----------------

RNA-seq, ChIP-seq and Methyl-seq data have been deposited in DNA Data Bank of Japan (DDBJ) with the accession numbers DRA004841, DRA004842 and DRA006579, respectively.

Statistical analysis {#s4-20}
--------------------

Quantitative data are presented as means ± s.d. and were analyzed with the unpaired Student's *t* test. A p value of \< 0.05 was considered statistically significant.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Fam60a is a component of the mSin3a-Hdac transcriptional corepressor complex and inhibits Tet-mediated DNA demethylation\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered for immediate publication in *eLife*.

The major concern is that the regulation of DNA methylation and Tet1 activity by Fam60a is not sufficiently well established. Furthermore, the different sections of the manuscript -- developmental functions of Fam60, biochemistry and links with the Sin3a complex and the genomics -- do not connect well and read almost as three different manuscripts.

Given that responding to the reviewers\' comments is likely to take more than the two month period allowed for revisions, we think it best to formally reject the paper but would encourage re-submission once the concerns have been addressed. Although this will be considered a new manuscript, we would make every effort to return the paper to the original reviewers.

*Reviewer \#1:*

The manuscript entitled \"Fam60a is a component of the mSin3a-Hdac transcriptional corepressor complex and inhibits Tet-mediated DNA demethylation\" shows that Fam60a modulates DNA methylation, possibly by modulating Tet activity. The impact of this finding is that no function has been previously associated with Fam60a, and its possible association with methylation in stem cells is significant.

Having previously found differential expression of Fam60a in ESCs and differentiated cells, the authors examined expression throughout development and in adults to find that expression correlated with somatic stem cells in the intestinal crypt. They developed a *Fam60a-CreERT2* transgene to examine lineage expression in crypt cells, and found expression in the villi that migrated up to the tip. They then developed a knockout to find that embryos die in mid-gestation, and have general organ hypoplasia as well as cardiac outflow tract defects. They developed a *Fam60a::Venus* BAC transgenic mouse to identify interacting proteins using IP-mass spec. Interestingly, mSin3A and HDAC1 were found as strong interacting partners. They carried out ChIP-seq to find that Fam60a is recruited to promoter regions of genes to regulate gene expression, and compared these data with RNASeq. The authors show convincing evidence that 5-hydroxymethylation, a product of Tet activity, increases when Fam60a is absent in transfected NIH3T3 cells, yet do not provide direct evidence for how Fam60a might be doing so. A further concern is that upon comparing mutant and wild type embryos for differential methylation at putative Fam60a target genes, only one gene appears to be differentially methylated. Therefore, how differential methylation by Tet is modulated by Fam60a remains obscure.

The manuscript reads as if it is two different papers. One story touches on the role of Fam60a in development and intestinal stem cells, and the second assesses its biochemical function. This is somewhat of a problem for genes for which no function is known, but I feel that the manuscript would be more appealing to a wider audience if it could be tightened up somewhat to focus on the role of Fam60a in stem cells and methylation. The story should also be linked again in the Discussion.

The embryo expression at E9.5 would be very difficult for anyone who is not an expert to interpret, and could be placed in supplementary, focusing on intestinal expression. The lineage tracing experiment in intestinal villi is very nice, but loses relevance in Figure 1. Further, arrows pointing to key regions would help to guide the reader. It is not clear if the expression data correlate with the heart defects seen in the knockout, or if the KO mice have intestinal defects.

Some data are confusing and do not support the general claims of the authors. For example, ChIPSeq identified a large number of putative gene targets, yet differential methylation was found at only one -- *Adhfe1*. Without definition of these genes, interpretation of any biology is difficult. Sin3a-Hdac would normally alter AcH3K9, yet this mark did not change at Fam60a target genes in WT and mutant embryos. Some discussion of these unexpected data would be warranted.

*Reviewer \#2:*

The manuscript by Nabeshima et al. explores the role of Fam60a, a protein highly expressed in ESCs. The first part of the manuscript describes the phenotype of the mouse *Fam60* mutant and the protein interactions of Fam60 including the Sin3A complex components. This is followed by genomic analyses of *Fam60* binding and the transcriptome analyses of the mutant. The authors then attempt to build a link between Fam60 and Tet1 in cultured cells and mouse embryos. In my opinion, the majority of the genomic data appears very preliminary and the presented findings frequently do not support the drawn conclusions. The links between Fam60 action and Tet1 are especially weak and built mostly on conjecture. I also found the quality of the figures (especially the figures dealing with ChIP-seq and RNA-seq data) substandard while many other figures are not properly labelled and thus confusing. The biochemical data are of some interest due to the broad spectrum of Sin3 functions. Unfortunately however, those experiments were not followed up on. My comments and suggestions for improvement are outlined below.

What is the reason for including the MA plot in Figure 4A? It comes with very little/no explanation and if its only purpose is to show that *Fam60* loss results in bidirectional gene changes, then it is redundant with the B panel.

Did the authors assess whether the upregulated and downregulated genes are enriched in any specific GO categories? Some gene network analyses would also be very beneficial since there are currently no strong links between the mouse phenotypes and the RNA-seq data.

Why are there no error bars in Figure 4C? I assume that this data corresponds to the average of the three RNA-seq experiments.

I find it very problematic that the *Fam60* ChIP-seq experiment has no sequenced input controls (at least I couldn\'t find any). This can result in suboptimal peak calling and biased downstream analyses. For example, the observed enrichment of Fam60 peaks around the TSS could be partly due to the GC content sequencing bias.

What is the reason for the double peak in Figure 5A?

What does \"+/- 3Kb\" means in Figure 5C? Were the peaks extended for 3Kb in each direction before the overlaps were performed?

Subsection "Fam60a inhibits Tet1 activity in cultured cells": A Table is not an adequate tool for evolutionary comparisons. To properly address this issue, the authors should construct phylogenetic trees for DNMT proteins, Tet proteins, Sin3 and Fam60a. Also, how did the authors decide which organisms to include in this comparison? I would suggest including basal metazoans (such as Cnidaria and Ctenophora that are known to have DNA methylation) as well as cephalochordates and tunicates. A few insects known to employ DNA methylation (such as ants and wasps) can also be included.

Figure 6: The data presented in Figure 6 is not very convincing. The effect of *Fam60* on Tet1 expression is not very robust and the statistical significance of the presented differences appears to be low. Also, I find the system that the authors use highly artificial. A better experiment would be to generate *Fam60a^-/-^* cells (for example ESCs that express both proteins) and perform a Tet1 ChIP-seq to assess whether the loss of Fam60 results in increased binding of Tet1. This experiment could also be complemented with base-resolution hmC profiling.

Subsection "Aberrant promoter hypomethylation in *Fam60a^--/--^* mouse embryos" and Figure 7: It is very difficult to make any definite conclusions regarding the relationships between Tet1 and *Fam60* based on the example of a single gene and a \~15% decrease in methylation from a single experiment. The embryos at the examined stages are already differentiated and the tissue complexity can be a confounding factor in such analyses. The authors should attempt a more robust approach for detecting DNA methylation differences such as RRBS and WGBS and demonstrate more substantial links between the absence of Fam60a and a decrease in DNA methylation. To minimize the influence of tissue complexity at the desired embryonic stages, the experiment could be performed on tissues most affected by the loss of Fam60a such as heart or intestine. Also, to substantiate the link between Tet1 and *Fam60*, the authors should explore the developmental dynamics of the two proteins through ChIP-seq profiling in mouse embryos.

*Reviewer \#3:*

The authors have attempted to address the biological role of Fam60a. They show that the protein shows widespread expression during early mouse development; the expression becomes progressively restricted. The authors have next generated *Fam60a* knockout and show that the deletion of this gene leads to embryonic lethality after E10.5. In order to understand the role of Fam60a on the molecular level, the authors have identified Fam60a protein interactors -- this surprisingly revealed Sin3a complex. Fam60a was further shown to interact with gene promoters by ChIP-seq with the knockout leading both to gene activation and repression. While there is no obvious effect on AcH3k9 of the target genes, the link is made to Tet1 and DNA methylation through evolutionary conservation, this is followed by rather preliminary finding of Fam60a having a negative regulatory role on Tet1 activity.

Overall, I have a number of major comments:

1\) The characterisation of the generated mouse knockout requires an evidence at the Fam60a transcript or protein level.

2\) Is Sin3a complex affected in the absence of *Fam60a*?

3\) The \"evolutionary analysis of conservation\" -- this is certainly an interesting observation, however it should not be overstated as it lacks the rigor of the standard conservation and co-evolution analysis.

4\) ChIP-seq analysis: +/-3kb is too broad for the promoter region. The small overlap between Fam60a targets (ChIP-seq) and the genes down regulated in the KO suggests that the majority of the downregulated genes are probably due to secondary effects.

5\) My main comment -- the link between Tet1 and Fam60a is too preliminary to make any claims. I would definitely expect the authors to answer the type of questions they are raising in their Discussion to warrant publication of their study.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for submitting your article \"Fam60a is a component of the Sin3a complex and regulates DNA demethylation at a subset of gene promoters\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The authors have carried out further experiments on line with the reviewers\' suggestions. However a number of points, mainly involving restructuring the manuscript (points 1 and 2), together with some further data analysis if possible (points 3 and 4) and data presentation (point 5), need to be addressed:

1\) The regulation of DNA methylation should not be overemphasised since it did not completely convince the reviewers. We suggest this be toned down in its presentation with a title change along the lines of: \"Loss of *Fam60*, a Sin3 subunit results in XXX and is associated with hypomethylation on XXX promoters\".

2\) The manuscript would read better if it started with the biochemistry experiments i.e. largely confirming Streubel et al. findings. This could then be followed by the evolutionary comparisons, mice phenotypes, and genomics/transcriptomics data.

3\) The DNA methylation data should be analysed more carefully. If possible, the authors need to show heatmaps with DNA methylation levels over Fam60-bound promoters in the wild type and the knockout. This will immediately clarify to what extent Fam60 is associated with changes in DNA methylation.

4\) The average changes in DNA methylation in hyper- and hypo-methylated DMRs need to be included in the paper. This is important so that the reader can get an idea of what fraction of methylation is really changing upon the loss of *Fam60*.

5\) The authors should try not to copy and paste the plots directly from the programs that generated them into the manuscript. Most of the plots in this paper are copy-pasted screenshots. This type of visualisation is substandard.

*Reviewer \#1:*

The authors have performed additional experiments to try and strengthen the hypotheses presented in the initial submission. They have invested a significant effort into improving this manuscript, especially when taking into account that they moved their lab from Osaka to Kobe during this period.

The initial descriptions of the *Fam60a^-/-^* phenotypes and evolutionary studies have improved significantly. Also, additional validations associated with their genome-wide observations were helpful. Nevertheless, I still find the link between *Fam60* and DNA demethylation unsatisfying and I believe that more useful information could have been extracted from base-resolution bisulfite sequencing data (i.e. extent of mC change in the detected DMRs, heatmaps of mC over *Fam60*-bound promoters in wt and *Fam60a^-/-^* etc.). Also, some essential QC details such as non-conversion rates are missing.

Essentially, based on the presented data, I cannot find obvious links between *Fam60* and DNA demethylation. The reasons for this are following:

It is stated in the title and throughout the manuscript that \"*Fam60* regulates DNA demethylation on a subset of promoters\". Based on experiments presented in Figure 6, the reader is led to believe that *Fam60*, through an undefined mechanism, somehow inhibits Tet1 activity. Logically, this would then mean that a subset of promoters that is normally hypermethylated, would become hypomethylated in the *Fam60a^-/-^* condition. Nevertheless, the DMR analysis does not support this scenario as most hypomethylated DMRs appear associated with intronic regions. Also, this \"subset\" of promoters is not identified in the manuscript and remains limited to a handful of examples that display modest DNA methylation differences, (Figure 7), that could just be attributed to pleiotropic effects.

In total, I am supportive of this manuscript, however, I would urge the authors to:

1\) Change the title and remove any sentences/paragraphs that claim links between *Fam60a^-/-^* and DNA demethylation.

2\) To discuss their findings better in the context of a recently published study (Streubel et al., 2017), where Fam60a was described as a Sin3 complex component. While the Streubel et al. study is indeed briefly mentioned in the Discussion, more credit should be given there.

*Reviewer \#2:*

The manuscript entitled \"Fam60a is a component of the mSin3a-Hdac transcriptional corepressor complex and inhibits Tet-mediated DNA demethylation\" shows that Fam60a modulates DNA methylation, possibly by modulating Tet activity. Because a manuscript published in EMBO J in 2017 describes the link between Fam60a, mSin3a-Hdac and Tet1, the primary finding in this manuscript is the knockout mouse phenotype, which is incomplete, and the mechanistic link with Tet1, which remains ambiguous. This paper is not referenced.

The authors examine expression of *Fam60a*, but the best example is in the intestinal crypt; even so, this does not link with the story. A knockout shows that embryos die in mid-gestation, and have general organ hypoplasia as well as cardiac outflow tract defects. A *Fam60a::Venus* BAC transgenic mouse was used to rescue the phenotype. Under several different IP conditions, they identified several important interacting partners, including mSin3A and HDAC1, but not Tet1. Tet1 was found as a partner in the competing paper. ChIP-seq revealed that Fam60a is recruited to promoter regions of genes to regulate gene expression, these data are compared with RNASeq to identify putative targets. Methylation differs at these target loci, suggesting that demethylation increases in the absence of *Fam60a*. The authors show convincing evidence that 5-hydroxymethylation, a product of Tet activity, increases when Fam60a is absent in transfected NIH3T3 cells, yet do not provide direct evidence for how Fam60a might be doing so. An evolutionary comparison suggests that Fam60a evolved at around the same time as Tet1. Even so, how differential methylation by Tet is modulated by Fam60a remains obscure, and the link to Tet1 is superficial. This manuscript does not extend or clarify the findings presented in the other manuscript.

Moreover, the EMBO J manuscript shows that the complex binds to the H3K4me3 mark. In this regard, did H3K4me3 change at the targets identified? AcH3K9, a target of HDAC, did not differ.

10.7554/eLife.36435.059

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

During revision of our manuscript, a related paper titled "Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells required for self-renewal" was published by Streubel et al., 2017. The data in this paper overlap in part and are consistent with our results. Streubel et al. thus also show that Fam60a is a component of the Sin3a-Hdac complex. However, the two studies are substantially different in that Streubel et al. examine the role of Fam60a in ES cells, whereas we have characterized the phenotype of Fam60a knockout mice. Furthermore, we now also present evidence that Fam60a controls gene expression at least in part by regulating the DNA methylation status of a subset of gene promoters. Our paper thus still reports many new findings, and we believe that it is worthy of publication in *eLife*. We now refer to the study of Streubel et al. in our revised manuscript (Discussion, second paragraph) and therefore include it in the list of references.

> Reviewer \#1:
>
> The manuscript entitled \"Fam60a is a component of the mSin3a-Hdac transcriptional corepressor complex and inhibits Tet-mediated DNA demethylation\" shows that Fam60a modulates DNA methylation, possibly by modulating Tet activity. The impact of this finding is that no function has been previously associated with Fam60a, and its possible association with methylation in stem cells is significant.
>
> Having previously found differential expression of Fam60a in ESCs and differentiated cells, the authors examined expression throughout development and in adults to find that expression correlated with somatic stem cells in the intestinal crypt. They developed a Fam60a-CreERT2 transgene to examine lineage expression in crypt cells, and found expression in the villi that migrated up to the tip. They then developed a knockout to find that embryos die in mid-gestation, and have general organ hypoplasia as well as cardiac outflow tract defects. They developed a Fam60a::Venus BAC transgenic mouse to identify interacting proteins using IP-mass spec. Interestingly, mSin3A and HDAC1 were found as strong interacting partners. They carried out ChIP-seq to find that Fam60a is recruited to promoter regions of genes to regulate gene expression, and compared these data with RNASeq. The authors show convincing evidence that 5-hydroxymethylation, a product of Tet activity, increases when Fam60a is absent in transfected NIH3T3 cells, yet do not provide direct evidence for how Fam60a might be doing so. A further concern is that upon comparing mutant and wild type embryos for differential methylation at putative Fam60a target genes, only one gene appears to be differentially methylated. Therefore, how differential methylation by Tet is modulated by Fam60a remains obscure.
>
> The manuscript reads as if it is two different papers. One story touches on the role of Fam60a in development and intestinal stem cells, and the second assesses its biochemical function. This is somewhat of a problem for genes for which no function is known, but I feel that the manuscript would be more appealing to a wider audience if it could be tightened up somewhat to focus on the role of Fam60a in stem cells and methylation. The story should also be linked again in the Discussion.

We now provide genome-wide methylation data (new Figure 8 and Figure 8---figure supplements 1 and 2) and focus on the role of Fam60a in DNA methylation. Our results suggest that Fam60a controls gene expression at least in part by regulating DNA methylation at a subset of gene promoters. We have also modified the Discussion section to address the possible link between the role of Fam60a in development and its biochemical function (Discussion, first paragraph).

> The embryo expression at E9.5 would be very difficult for anyone who is not an expert to interpret, and could be placed in supplementary, focusing on intestinal expression. The lineage tracing experiment in intestinal villi is very nice, but loses relevance in Figure 1. Further, arrows pointing to key regions would help to guide the reader. It is not clear if the expression data correlate with the heart defects seen in the knockout, or if the KO mice have intestinal defects.

We have reorganized these data according to the reviewer's suggestions. The revised Figure 1 now focuses on intestinal expression of Fam60a and includes the lineage tracing experiment for intestinal villi. The remaining expression data have been moved to Figure 1---figure supplement 1. The *Fam60a* KO mice manifest both heart and intestinal defects. Abnormal gut looping in the mutant embryos is now shown in the new Figure 2---figure supplement 3. We also now show *Fam60a* expression in the developing heart (new Figure 2G). *Fam60a* is expressed predominantly in the outflow tract and right ventricle of the heart at E13.5, consistent with our observation that the right ventricle is hypoplastic in KO mice. We modified the text of the Results section accordingly (subsection "Developmental defects in *Fam60a* mutant mice", first paragraph).

> Some data are confusing and do not support the general claims of the authors. For example, ChIP-Seq identified a large number of putative gene targets, yet differential methylation was found at only one -- Adhfe1. Without definition of these genes, interpretation of any biology is difficult. Sin3a-Hdac would normally alter AcH3K9, yet this mark did not change at Fam60a target genes in WT and mutant embryos. Some discussion of these unexpected data would be warranted.

We have now included data on genome-wide DNA methylation in WT and *Fam60a* KO embryos, showing that many promoter regions (including that of *Adhfe1*) are hypomethylated in the mutant embryos (new Figure 8 and Figure 8---figure supplements 1 and 2). As pointed out by the reviewer, the amount of AcH3K9 at Fam60a target genes was not altered in the mutant embryos. We have now performed a similar analysis for Fam60a target genes in control and *Fam60a*^--/--^ ES cells and found that the level of AcH3K9 at these genes was significantly increased in the mutant cells (Figure 4---figure supplement 2C). These data are now described in the Results section (subsection "Fam60a is recruited to promoter regions and regulates gene expression", last paragraph).

> Reviewer \#2:
>
> The manuscript by Nabeshima et al. explores the role of Fam60a, a protein highly expressed in ESCs. The first part of the manuscript describes the phenotype of the mouse Fam60 mutant and the protein interactions of Fam60 including the Sin3A complex components. This is followed by genomic analyses of Fam60 binding and the transcriptome analyses of the mutant. The authors then attempt to build a link between Fam60 and Tet1 in cultured cells and mouse embryos. In my opinion, the majority of the genomic data appears very preliminary and the presented findings frequently do not support the drawn conclusions. The links between Fam60 action and Tet1 are especially weak and built mostly on conjecture. I also found the quality of the figures (especially the figures dealing with ChIP-seq and RNA-seq data) substandard while many other figures are not properly labelled and thus confusing. The biochemical data are of some interest due to the broad spectrum of Sin3 functions, unfortunately however, those experiments were not followed up on. My comments and suggestions for improvement are outlined below.
>
> What is the reason for including the MA plot in Figure 4A? It comes with very little/no explanation and if its only purpose is to show that Fam60 loss results in bidirectional gene changes, then it is redundant with the B panel.

We have now omitted this plot in the revised manuscript.

> Did the authors assess whether the upregulated and downregulated genes are enriched in any specific GO categories? Some gene network analyses would also be very beneficial since there are currently no strong links between the mouse phenotypes and the RNA-seq data.

As suggested by the reviewer, we performed gene ontology analysis, with the results being shown in new Figure 4---figure supplement 1. We found that genes related to nutrient responses are up-regulated and those related to lipid biosynthesis are down-regulated in the mutant embryos. These findings are now described in the text of the Results section (subsection "Fam60a is recruited to promoter regions and regulates gene expression", first paragraph).

> Why are there no error bars in Figure 4C? I assume that this data corresponds to the average of the three RNA-seq experiments.

The RNA-seq data are indeed from three independent experiments, and error bars have now been added to the figure.

> I find it very problematic that the Fam60 ChIP-seq experiment has no sequenced input controls (at least I couldn\'t find any). This can result in suboptimal peak calling and biased downstream analyses. For example, the observed enrichment of Fam60 peaks around the TSS could be partly due to the GC content sequencing bias.

The input DNA has been sequenced by NGS, which is included in the data deposited to DNA Data Bank of Japan (DDBJ) with the accession numbers DRA004842.

> What is the reason for the double peak in Figure 5A?

Sin3a and H3K4me3 also show two peaks in previous studies by other researchers (for example, see Bowman et al., 2014). The two peaks seem to represent the regions immediately upstream and downstream of the transcription start site.

> What does \"+/- 3Kb\" means in Figure 5C? Were the peaks extended for 3Kb in each direction before the overlaps were performed?

The designation " ± 3 kb" means the region between --3 kb and +3 kb relative to the transcription start site, as has now been clarified in the legend.

> Subsection "Fam60a inhibits Tet1 activity in cultured cells": A Table is not an adequate tool for evolutionary comparisons. To properly address this issue, the authors should construct phylogenetic trees for DNMT proteins, Tet proteins, Sin3 and Fam60a. Also, how did the authors decide which organisms to include in this comparison? I would suggest including basal metazoans (such as Cnidaria and Ctenophora that are known to have DNA methylation) as well as cephalochordates and tunicates. A few insects known to employ DNA methylation (such as ants and wasps) can also be included.

We have now constructed a phylogenetic tree for Fam60 proteins and provided a more detailed analysis of the phylogeny of Fam60, Dnmt, Tet, and Sin3 proteins and their relation to the absence or presence of DNA methylation (new Figure 6A and B).

> Figure 6: The data presented in Figure 6 is not very convincing. The effect of Fam60 on Tet1 expression is not very robust and the statistical significance of the presented differences appears to be low. Also, I find the system that the authors use highly artificial. A better experiment would be to generate Fam60a^-/-^ cells (for example ESCs that express both proteins) and perform a Tet1 ChIP-seq to assess whether the loss of Fam60 results in increased binding of Tet1. This experiment could also be complemented with base-resolution hmC profiling.

As suggested by the reviewer, we generated *Fam60a*^--/--^ ES cells, which retained pluripotency markers, and performed a Tet1 ChIP assay as well as an AcH3K9 ChIP assay (new Figure 4---figure supplement 2). The level of AcH3K9 at the promoter regions of three Fam60a target genes was significantly increased in *Fam60a*^--/--^ ES cells compared with control cells (Figure 4---figure supplement 2C). However, the level of Tet1 at the promoters of these genes was not affected by the absence of Fam60a (Figure 4---figure supplement 2D). The recruitment of Tet1 to these promoter regions thus appeared to be independent of Fam60a. Given that Fam60a appeared to attenuate Tet1 function in transfected cells (Figure 6C-F), Fam60a may regulate Tet1 by inhibiting its enzymatic activity rather than by preventing its recruitment to gene promoters. We have now addressed this issue in the text (Discussion, last paragraph).

> Subsection "Aberrant promoter hypomethylation in Fam60a^--/--^ mouse embryos" and Figure 7: It is very difficult to make any definite conclusions regarding the relationships between Tet1 and Fam60 based on the example of a single gene and a \~15% decrease in methylation from a single experiment. The embryos at the examined stages are already differentiated and the tissue complexity can be a confounding factor in such analyses. The authors should attempt a more robust approach for detecting DNA methylation differences such as RRBS and WGBS and demonstrate more substantial links between the absence of Fam60 and a decrease in DNA methylation. To minimize the influence of tissue complexity at the desired embryonic stages, the experiment could be performed on tissues most affected by the loss of Fam60 such as heart or intestine. Also, to substantiate the link between Tet1 and Fam60, the authors should explore the developmental dynamics of the two proteins through ChIP-seq profiling in mouse embryos.

As suggested by the reviewer, we examined DNA methylation more comprehensively in WT and *Fam60a*^--/--^ embryos. The results are now shown in the new Figure 8 and Figure 8---figure supplements 1 and 2 and are described in the text (subsection "Differentially methylated regions in the genome of *Fam60a^--/--^* embryos"). The body and CpG shore regions of all genes rather than the whole genome were examined by bisulfite sequencing, given that this approach is equally meaningful and more effective. There was no apparent difference in the global methylation level between WT and mutant embryos, with \~45% of CpGs being methylated in both. However, we detected 7245 differentially methylated regions (DMRs), 3049 of which were hypermethylated and 4196 hypomethylated in the *Fam60a* mutant embryos. Among the top 500 DMRs of each type, 83 (17%) hypermethylated and 254 (51%) hypomethylated regions corresponded to Fam60a binding regions detected by ChIP-seq, with the hypomethylated DMRs thus being enriched in Fam60a binding sites. As expected, *Adhfe1* was included in the top 500 hypomethylated DMRs (Figure 8---figure supplement 2).

> Reviewer \#3:
>
> The authors have attempted to address the biological role of Fam60a. They show that the protein shows widespread expression during early mouse development; the expression becomes progressively restricted. The authors have next generated Fam60a knockout and show that the deletion of this gene leads to embryonic lethality after E10.5. In order to understand the role of Fam60a on the molecular level, the authors have identified Fam60a protein interactors -- this surprisingly revealed Sin3a complex. Fam60 was further shown to interact with gene promoters by ChIP-Seq with the knockout leading both to gene activation and repression. While there is no obvious effect on AcH3k9 of the target gene, the link is made to Tet1 and DNA methylation through evolutionary conservation, this is followed by rather preliminary finding of Fam60a having a negative regulatory role on Tet1 activity.
>
> Overall, I have a number of major comments:
>
> 1\) The characterisation of the generated mouse knockout requires an evidence at the Fam60a transcript or protein level.

We now provide RT-qPCR and immunoblot data (Figure 2---figure supplement 1C and D) showing the loss of Fam60a mRNA and protein in the mutant embryos. These results are also briefly mentioned in the text (subsection "Developmental defects in *Fam60a* mutant mice", first paragraph).

> 2\) Is Sin3a complex affected in the absence of Fam60a?

We examined proteins co-immunoprecipitated with Sin3a from extracts of *Fam60a*^--/--^ and control ES cells (new Figure 3---figure supplement 3). The formation of the Sin3a-Hdac complex did not appear to be affected by the absence of Fam60a. These results are now described in the text (subsection "*Fam60a* interacts with components of the Sin3a-Hdac complex", last paragraph).

> 3\) The \"evolutionary analysis of conservation\" -- this is certainly an interesting observation, however it should not be overstated as it lacks the rigor of the standard conservation and co-evolution analysis.

We have now constructed a phylogenetic tree for Fam60 proteins and provided a more detailed analysis of the phylogeny of Fam60, Dnmt, Tet, and Sin3 proteins and their relation to the absence or presence of DNA methylation (new Figure 6A and B). We have also toned down the description of this issue to avoid overstatement (subsection "Association of Fam60a with DNA methylation and Tet", first paragraph).

> 4\) ChIP-Seq analysis: +/-3kb is too broad for the promoter region. The small overlap between Fam60a targets (ChIP-Seq) and the genes down regulated in the KO suggests that the majority of the downregulated genes are probably due to secondary effects.

As shown in Figure 4A, only 26% (45/172) of down-regulated genes in the mutant mice contain a Fam60a binding site, suggesting that attenuation of the expression of most of the down-regulated genes is due to a secondary effect of Fam60a loss. We have now addressed this point in the Results section (subsection "Fam60a is recruited to promoter regions and regulates gene expression", last paragraph). Promoter regions as defined as ± 1 kb relative to the transcription start site constitute only 1.1% of the genome (new Figure 5---figure supplement 1B) but contain 13.4% or 16.8% of Fam60a binding sites in two independent ChIP-seq experiments (Figure 5B and Figure 5---figure supplement 1B), indicating that Fam60a binding sites are indeed enriched at promoter regions.

> 5\) My main comment -- the link between Tet1 and Fam60a is too preliminary to make any claims. I would definitely expect the authors to answer the type of questions they are raising in their Discussion to warrant publication of their study.

To address the link between Tet1 and Fam60a, we examined the association of Tet1 and AcH3K9 with the promoters of three Fam60a target genes in *Fam60a*^--/--^ and control ES cells (new Figure 4---figure supplement 2). The level of AcH3K9 was significantly increased at each of these promoter regions in the *Fam60a*^--/--^ ES cells (Figure 4---figure supplement 2C). In contrast, the level of Tet1 associated with these promoters was not affected by the absence of Fam60a (Figure 4---figure supplement 2D). The recruitment of Tet1 to these promoter regions thus appears to be independent of Fam60a. Given that forced expression of Fam60a attenuated Tet1 function in NIH3T3 cells (Figure 6C--F), Fam60a may regulate Tet1 by inhibiting its enzymatic activity rather than by preventing its recruitment to gene promoters. We have now addressed this issue in the text of the revised manuscript (Discussion, last paragraph). We have also changed the title of our paper to remove reference to Tet1.

\[Editors\' note: the author responses to the re-review follow.\]

> The authors have carried out further experiments on line with the reviewers\' suggestions. However a number of points, mainly involving restructuring the manuscript (points 1 and 2), together with some further data analysis if possible (points 3 and 4) and data presentation (point 5), need to be addressed:
>
> 1\) The regulation of DNA methylation should not be overemphasised since it did not completely convince the reviewers. We suggest this be toned down in its presentation with a title change along the lines of: \"Loss of Fam60, a Sin3 subunit results in XXX and is associated with hypomethylation on XXX promoters\".

We have changed the title according to the suggestion. The new title is "Loss of Fam60a, a component of the Sin3a complex, results in embryonic lethality and is associated with aberrant methylation at a subset of gene promoters." We used "aberrant methylation" instead of hypomethylation because a significant portion of DMRs is hypermethylated.

> 2\) The manuscript would read better if it started with the biochemistry experiments i.e. largely confirming Streubel et al. findings. This could then be followed by the evolutionary comparisons, mice phenotypes, and genomics/transcriptomics data.

We have re-structured the manuscript according to the editors' suggestion. Thus the paper starts with the biochemistry experiments, which is followed by the evolutionary comparisons, mice phenotypes, and genomics/transcriptomics data.

> 3\) The DNA methylation data should be analysed more carefully. If possible, the authors need to show heatmaps with DNA methylation levels over Fam60-bound promoters in the wild type and the knockout. This will immediately clarify to what extent Fam60 is associated with changes in DNA methylation.

As suggested by the editors, we now show heatmaps with DNA methylation levels over Fam60-bound promoters in the wild type and the knockout (Figure 8---figure supplement 2). Hypomethylation was commonly observed at the Fam60a-binding regions. While a number of DMRs were clearly detected, there was no obvious difference in this type of presentation between the wild-type and *Fam60a*^--/--^ embryos (Figure 8---figure supplement 2). This is probably because only a subset of gene promoters was affected in the mutant (Figure 8A), and because the changes of DNA methylation between the wild-type and the mutant are small (Figure 8---figure supplement 1, Figure 8---figure supplement 3).

> 4\) The average changes in DNA methylation in hyper- and hypo-methylated DMRs need to be included in the paper. This is important so that the reader can get an idea of what fraction of methylation is really changing upon the loss of Fam60.

We now show the average changes in DNA methylation in hyper- and hypo-methylated DMRs in Figure 8---figure supplement 3. Among 7245 DMRs detected, the average changes of DNA methylation were 11.87% and 10.99% for hyper- and hypomethylated DMRs, respectively (subsection \"Differentially methylated regions in the genome of *Fam60a^--/--^* embryos", second paragraph).

> 5\) The authors should try not to copy and paste the plots directly from the programs that generated them into the manuscript. Most of the plots in this paper are copy-pasted screenshots. This type of visualisation is substandard.

We have improved the quality of all figures such as by removing copy-pasted screenshots.

[^1]: These authors contributed equally to this work.
